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Abstract 
Medical statistics has important applications in cancer research, in particular through 
the analysis of censored survival data. Moreover, breast cancer is responsible for 
thousands of deaths each year in Britain, and is among the leading causes of mortality 
among women. This thesis is about the robust application of neural networks to survival 
analysis of breast cancer patients, taking advantage of its non-linearity and flexibility 
but providing an automatic mechanism to prevent over fitting of the data. 
Censorship is a feature of survival data, which arises when the endpoint of interest 
cannot be observed for a particular individual. In this thesis, a Bayesian regularised 
neural network model that accommodates censorship is introduced, extending the 
"Partial Logistic Artificial Neural Network (PLANN) model". Within the neural 
network model, categorical data are treated differently from ordinal data and requires 
bias correction for the network prediction when the data distribution is heavily skewed. 
The network also uses the Automatic Relevant Determination (ARD) technique within 
the Bayesian regularisation framework, to perform a backward model elimination. The 
use of non-linear variable selection methods leads to the identification of pairwise 
interactions between covariates that may be implicitly modelled by the neural network 
or explicitly added to Cox regression, which is the most commonly used statistical 
modelling tool for survival analysis. Both methods were applied to the modelling of 
post-operative mortality with 5 years follow-up of two patients groups. The first group 
was used to design and compare the two methods, and comprises patients recruited 
between 1983-1989, The second group is used to validate the model's performance, and 
comprises patients recruited between 1990-1993. The two sets of data were divided into 
two cohorts each, according to the clinical separation criteria for low-and high-risk. The 
missing data in the data sets were treated as a separate category. Performance estimation 
for the design data set was carried out through the use of v-fold cross validation. 
Patients were also divided into mortality risk groups using the log-rank test applied to a 
prognostic index, and the predicted survivorship for prognostic groups are assessed by 
the observed survivorship, which is described by the Kaplan-Meier survival estimation. 
The robustness of Cox regression was explained by explicitly plotting the estimated 
hazard over time, showing that deviations from proportionality of the hazards are minor. 
The proposed extension of the PLANN model has successfully identified interaction 
terms that were added to the Cox regression model to improve prognostic group 
separation and attribute specificity. 
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1. Introduction 
1.1 Objectives of the thesis 
1.2 Thesis structure 
Chapter 1: Introduction 
1 Introduction 
This chapter gives an overview the issue in survival analysis that is this thesis, and the 
methodologies proposed in it, are intended to address. This is followed by a review of 
the structure of the remaining thesis chapters. 
1.1 Objectives of the thesis 
Cancer research is generally focused on improving patient survival rates, whether 
through early detection, development of new drugs, or improvements in therapy. 
However, surgery and adjuvant therapy carry with them significant side effects. 
Treatment and surgery are assigned following guidance based on standard clinical 
factor measurements, often without direct reference to accurate estimates of individual 
survivorship, Smith (2000). The main objective of this thesis is to predict the 
survivorship over time for individual patients through the use of Cox regression and 
neural network models, and to permit a clinical interpretation to be ascribed to the 
predictive results obtained from both of the models. 
Survival data have special characteristics, for instance the data are not symmetrically 
distributed with a trend to be positively skewed, that is having a longer `tail' to the right 
of time intervals. Also censorship is an inherent feature of survival data and arises when 
the end-point for particular individuals is not the event of interest, making the outcome 
beyond a fixed time point indeterminate. However, excluding these data from the model 
can introduce significant bias, Ravdin and Clark (1992) and Brown et al (1997), 
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therefore these patients must remain in the study for the time they were observed. An 
example of censorship would be an early death from a cause unrelated to the breast 
cancer, sometimes called an intercurrent death. 
The most widely used statistical modelling method for censored data is Cox regression, 
Cox (1972), which is based on the assumption that the hazards of different patient 
groups remain proportional to the baseline hazard over time. Some other well-known 
parametric statistical methods, are the Weibull model and accelerated failure time 
model, Collett (1994). Efron (1988) also proposed a flexible non-linear model using 
cubic spline and Bennett (1983) introduced log-logistic regression models for survival 
data, which require proportionality of the survival log-odds ratio, instead of the 
probability of death in a particular time interval that is the hazard ratio. 
Artificial neural networks (ANN) are non-linear, semi-parametric models that have 
recently been considered as alternative methods for analysing survival data. Radvin et 
al (1992) proposed an extension of proportional hazard model using a standard MLP 
architecture with multiple output nodes to accommodate the censorship, where each 
output node represented a time interval. However, for a monthly study, this method 
requires many output nodes. Biganzoli et al (1996) introduced the Partial Logistic 
Artificial Neural Network model (PLANN), which is a straightforward Multi-Layer 
Perceptron, MLP, where censorship is encoded via the data structure. By assigning 
target values of zero and one to each patient record while observed alive, or when event 
of interest happened in that time interval, respectively, but omitting any target values 
after censorship. A patient will remain in the population at risk only while observed, but 
is removed from the study when the outcome for that time interval is not observed. This 
-3- 
Chapter 1: Introduction 
model has advantage of not requiring proportionality of the hazards overtime, and can 
implicitly model interactions between variables. However, neural networks are prone to 
over-fitting unless careful regularisation is applied. The Bayesian neural network 
approach (MacKay, 1992a, b) is commonly used to regularise binary classification 
problems without censorship including soft model selection through Automatic 
Relevance Determination (ARD) where the hyperparameters regularising the objective 
function suppress irrelevant variables. The magnitude of the hyperparameters thus 
provides a rank order that reflects the relative importance of the variables to the model 
predictions. Neural network models are often benchmarked with traditional statistical 
tools, Groves (1999), Radvin and Clark (1992), and in this study the regularised 
PLANN model is compared with Cox regression. 
In this thesis, a longitudinal study is conducted where the modelling methodologies are 
developed using a data set with 1,616 records and tested with a further 1,653 records. 
They all comprise women patients admitted to Manchester Christie Hospital during 
1983 to 1989, and 1990 to 1993, respectively, who were followed-up for at least 5 years 
after surgery. These two sets of data contain demographic information, clinical 
investigations, laboratory test results, post-surgery and treatment assignment, but do not 
include any genetic or life style information. Each of the data sets is divided into two 
cohorts on the basis of clinical staging, divided generically into low-and high-risk. 
Within these data sets, some of the variables contained large amounts of missing values. 
The attribute `missing' was treated as a separate category, although investigations were 
also carried out predicting missing values using Nominal Logistic Regression. 
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Assigning patients into prognostic risk groups is of considerable importance in the 
management of breast cancer patients. A key objective of this thesis is to partition them 
into prognostic groups based upon their risk of mortality. The observed survival for 
particular patients groups is estimated non-parametrically by the Kaplan-Meier survival 
estimation (1958). In this thesis, we propose an extension of the PLANN model to 
include the estimation of hyperparameters within the Bayesian framework. The 
extended PLANN model is then applied to two monthly studies of mortality risk 
following breast cancer re-section, with follow-up to 60 months, for each of the two 
cohorts. The patients in each cohort are partitioned into prognostic groups using a 
prognostic risk indice derived from (i) proportional hazards model analysis and (ii) the 
Bayesian implementation of PLANN. The performances of the two approaches are 
compared for the design data using 3- and 5-fold cross validation for high-risk cohort 
and low-risk cohort, respectively, and the generality of the results thus obtained is 
validated using the later cohorts. 
Forward step-wise variable selection was carried out using the proportional hazards 
model, and for the high-risk cohort additional variable selection was investigated also 
with ARD, using backward elimination. From a comparison of these two approaches to 
variable selection, specific interaction terms were identified that when integrated into 
the proportional hazards model, enhanced the differences in survivorship between the 
prognostic groups. 
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1.2 Thesis Structure 
In the next chapter, chapter (2), details of the two sets of data are described, including 
characteristics of the explanatory variables, the distribution of missing data and 
mechanism, and the process of filling-in the missing data using Nominal Logistic 
Regression and results. 
Chapter (3) summarises the literature review of the two modelling methods used to 
analysis the data, Cox regression and the Bayesian regularised neural networks. 
The data analysis results using Cox regression are reported in chapter (4) using two 
approaches, predicting the event occurrence time and predicting the survivor function 
over time for identified mortality risk groups. The event occurrence time prediction for 
individuals is defined by the cross point of the threshold value and the estimated 
survival function over time, and presented with the Receiver Operating Characteristic 
(ROC) curve, Hanley (1989). This approach is considered to be sub-optimal. Then the 
data are divided into low- and high-risk cohorts according to the clinical staging criteria 
in the second approach. In each cohort, patients are divided into mortality risk groups 
according to the risk indexes by observing the indexes natural grouping behaviour and 
the log-rank test. The accuracy of the Cox survivorship prediction for each risk group is 
assessed by comparison with the observed survivor function, which is described by 
Kaplan-Meier estimate. Model selection in both of the approaches is implemented with 
the forward elimination procedure. 
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The alternative modelling method used in this thesis is Bayesian neural networks with 
the evidence approximation. Chapter (5) reports a preliminary study of Bayesian neural 
networks handling censored survival data, using the same two approaches as used 
earlier with Cox regression. Although neural networks give betters result than the Cox 
regression for event prediction, the result cannot be concluded to be significant. This 
chapter only reports the result for the low-risk cohort from the second approach, 
survivorship prediction for risk groups, using the PLANN model. Within these sections, 
two new modelling improvement techniques are introduced, baseline population 
assignment for categorical data and marginalising network output towards the averaged 
hazard of the data, that are necessary since the data are heavily skewed. The 
proportionality of hazards between risk groups is visualised simply by displaying the 
predicted hazard for each group over time. 
A similar neural networks analysis is repeated for the high-risk cohort, which is 
summarised in chapter (6). Moreover, model selection using ARD is investigated. The 
selected models help to identify interactions between variables, which then can be 
explicitly represented in Cox regression models. The difference between the results by 
the neural networks and Cox regression for the low-risk cohort, lead to a further search 
for interaction terms. As a result, two pairs of interactions are identified, which apply 
separately to the highest and the lowest survival patients groups. However, these two 
interactions between variable pairs cannot be efficiently combined in a single Cox 
model, as they work against each other. 
In the longitudinal study, the preferred Cox regression and PLANN models are tested 
with an independent data set, the results of which are shown for both cohorts in chapter 
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(7). The results show that the data distribution and the survivorship over time of two 
data sets are different. 
The investigation of handling missing data methods is summarised in chapter (8). In this 
chapter, the results for the filled-in data using nominal logistic regression are reported. 
At this stage, the analysis is by Cox regression and variable interactions are not 
considered. The results using the previously defined models for each cohort are 
compared with the newly selected models, filling-in the missing data. The only 
difference between the predictions occurs in the high-risk cohort, since one of the data 
separation criteria contained large amounts of missing data. 
Finally, the discussion of the results between two cohorts recruited over consecutive 
time periods and the comparison of two modelling methods are summarised in the 
conclusion, chapter (9). 
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Chapter 2: Literature Review 
2. Literature Review 
2.1 Review of statistic literature on survival analysis 
In many clinical studies, it is important to estimate the probability that set intervals of 
time occur before an event of interest, which may be death ascribed to a particular 
cause, recurrence of a disease or another prescribed event. The answer to these 
questions can be described with two functions, survivor function and hazard function, 
they are of central interest for analysing survival data. Survival data are not amenable to 
standard statistical procedures used in data analysis because of censorship and the 
unsymmetrical distributions of the data. The survival time of the data often appear to be 
positively skewed, that is, having a longer `tail' to the right of the time intervals. The 
life-table and Kaplan-Meier methods (1958) are most commonly used for estimating the 
survival and hazard functions given an observed population. They are known as non- 
parametric, since they do not need a specific assumption to be made about the 
underlying distribution of the survival time or indeed any covariate dependencies. An 
other special feature of survival data is censorship, where the end point of an individual 
is not the event of interest, such as those who survived beyond the end of the study and 
those who are lost of follow-up, for instance due to death from an unrelated cause. The 
event of interest is usually either the death caused by a particular disease, or the 
recurrence of a disease. 
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The most commonly used modelling methods for survival analysis are the Cox 
Regression Model and the Weibull Model, Collett (1994). The Weibull Model was 
introduced in 1951 in the context of industrial reliability testing and depends on a 
particular form of probability distribution for the hazard function, hence it is referred to 
as a parametric model. Alternatively, Cox regression, to be described in section (2.2), 
has been used extensively for survival analysis for more than 20 years and is also 
known as the Proportional Hazards Model. This model has much flexibility and 
widespread applicability. 
Another general family of survival models is given by the proportional odds model, also 
introduced by Cox (1972). It is a parametric method if the survival times for individuals 
are assumed to have a specific probability distribution, such as log-logistic distribution. 
One of the characteristics of the log-logistic proportional odds model is the involvement 
of time as an exponential variable. 
2.1.1 Survivor and Hazard Function 
Let t be the actual survival time of an individual, which can be regarded as a single 
nonnegative random variable, T. The hazard function h(t) is the probability that an 
event happens between time t and t+ bt for that individual, conditional upon the 
individual having survived up to that time. This is defined as 
h(t)=& öP(tST 
<t+btl t5 T) 
bt 
The survivor function gives the probability that the individual survives longer than a 
particular time t, so that 
S(t) = P(T >_ t), 
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and also S(t) = exp{-H(t)), 
I 
where H(t) =f h(u)du is called the cumulative hazard, Collett (1994). 
0 
2.1.2 Kaplan-Meier Estimate Survival Function 
The Kaplan-Meier estimate (1958), also known as product-limit estimate, is a non- 
parametric method capable of describing the survivor function for discrete censored 
survival data. Time is split into several time intervals, each includes at least one event 
case. The time intervals are not necessarily uniformly distributed. There is no interval 
starting at the censored time and the censored time interval falls between the death time 
intervals. There could be more than one individual observed to experience the event of 
interest at any particular event time as illustrated in figure (2.1), where C is the censored 
data and D represents the event cases. 
D 
DCDC 9 
F---F 
to t, t2 t3 
Figure (2.1): The structure of the event time and the relationship with the censored time 
of the Kaplan-Meier estimate. 
Suppose there are n individuals observed with observed times t, , t2 ,..., t,,. There are r 
death times in total, r <_ n., so the ordered death times are tc < t(2) < ... < t(J) , where 
j=1,2, 
..., r and 
d; denotes the number of death at that time interval. The probability of 
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an individual dying within that time interval is estimated by di / nj and the 
corresponding estimated survival rate for that interval is (n(j) - d(')) / n(J) . 
The probability of survival to time t is 
k nl 
Jl, S(t) 
ý 
-( 
J=l nj 
/ 
for t(k) <_ t< t(k+, ) , where k=1,2.... r, t(k+, ) 
is taken to be co and S(0) =l. A plot of the 
Kaplan-Meier survival estimation is a step function, the estimated probability of 
survival is constant between adjacent death times and the curve is decreased over time 
due to the multiplication of probability of survival of each time interval. The graphical 
presentation of survival curve is used widely. An example of Kaplan-Meier curves is 
illustrated in section (2.1.2.2) using the breast cancer data and also a Kaplan-Meier 
survival plot of each variable of breast cancer data is displayed in appendix (I). 
2.1.2.1 Standard Error and confidence interval of Kaplan-Meier estimate 
The Kaplan-Meier survival estimation can be written as 
S(t)=11 p; 
1=I 
for k =1,2,..., r, where pj = (nj - dj) /nj is the estimated probability that an 
individual survives from the beginning of time j through that interval. Then the number 
of individuals who survive through the interval can be assumed to have a binomial 
distribution with parameters nj and pj, where pj is the true probability of survival of 
that interval. The variance of a binomial random variable with parameters n, p is np(1- 
p) . 
Therefore, the variance for the observed number of survivors, nj -dj is given by 
k 
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var(nj -dj)=njpj(1-pj). 
The variance of p; can be estimated by pj (1- pj )/ nj . 
An approximation for the estimated standard error of the Kaplan-Meier estimate of the 
survivor function is given by 
1/L 
s. e. 
ý. S(t)}= di [S(t)] ý, 
i=, ni(ni - di) 
1/2 
for t(k) <_ t< t(k+l) , which is also known as Greenwood's formula, Collett (1994), chapter 
2. 
Once the standard error of the estimated survivor function has been calculated, 
confidence intervals for the estimated survivor functions can also be found. The 
confidence interval is a range of values around the estimate, gives a percentage level 
that the true underlying survivor function is included within the interval. In general a 
100(1-(x)% confident interval for the estimated survival is given by 
S(t) ± Za, 2s. e. 
{S(t) }. 
The ± za/2 are the upper and lower 1-a/2 points of the standard Normal Distribution 
respectively, where s. e. {S(t)} is the standard error of the estimated survivor function 
given by Greenwood's formula. 
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2.1.2.2 Illustration the use of Kaplan-Meier curves 
Table (2.1) displays the survival time and the status of 41 patients, status labelled with I 
represents the event of interest which is death due to breast cancer otherwise 0. Table 
(2.2) illustrates the necessary calculation needed to construct the Kaplan-Meier survival 
curve that displays in figure (2.2). 
Subjects 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Survival 15 61 42 12 61 45 57 19 7 39 45 20 45 30 61 52 18 
time in 
months 
Status 1 0 1 1 0 1 1 1 1 0 1 1 1 1 0 1 1 
Subjects 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 
Survival 57 28 32 17 26 27 61 23 44 61 27 44 52 37 8 47 61 
time in 
months 
Status 1 1 1 1 1 1 0 1 1 0 1 1 1 1 1 11 0 
Subjects 35 36 37 38 39 40 41 
Survival 61 27 61 14 61 7 24 
time in 
months 
Status 0 1 0 0 0 1 1 
Table (2.1): An example of 41 subjects with their survival time in months and status 
labelling. 
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Survival time in 
months(t) 
nj dj nj -di 
n. J 
(t) 
0 41 0 1.0000 1.0 
7 41 2 0.9756 0.9512 
8 39 1 0.9750 0.9268 
12 38 1 0.9743 0.9024 
15 37 2 0.9737 0.8774 
17 35 1 0.9722 0.8523 
18 34 1 0.9714 0.8272 
19 33 1 0.9706 0.8022 
20 32 1 0.9697 0.7771 
23 31 1 0.9687 0.7520 
24 30 1 0.9677 0.7270 
26 29 1 0.9666 0.7019 
27 28 3 0.9655 0.6267 
28 25 1 0.9614 0.6016 
30 24 1 0.9599 0.5766 
32 23 1 0.9583 0.5515 
37 22 1 0.9564 0.5264 
42 21 2 0.9545 0.5001 
44 19 2 0.9498 0.4475 
45 17 3 0.9441 0.3685 
47 14 1 0.9326 0.3422 
52 13 2 0.9283 0.2895 
57 11 2 0.9156 0.2369 
Table (2.2): Kaplan-Meier estimate of the survivor function for the data from table 
(2.1). 
ý 
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Figure (2.2): Graphically illustrates the Kaplan-Meier estimate of survivor function for 
the samples in table (2.1). 
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2.2 Statistical Modelling 
In the analysis of survival data, the centre of interest is the probability of a specific 
event occurring at some time after the recruitment date for that individual. Cox (1972) 
proposed the Proportional Hazard Model, which is referred to as "Cox regression" in 
the following context. It is the most commonly used statistical modelling method for 
discrete censored survival data, in which the hazard function is modelled directly as a 
linear summation of attribute values. The Cox regression is referred to as a semi- 
parametric model, since it does not make direct assumptions about the underlying 
distribution of the hazards in different groups, except that the hazard for different 
patient groups remains proportional to that of a pre-selected baseline population. It 
allows a non-constant hazard rate to be modelled and involves determining which 
combination of potential explanatory variables corresponds to the form of the hazard 
function and also estimates the hazard function itself for an individual. Cox regression 
can be described as predictive, whereas Kaplan-Meier estimation is descriptive. From 
the relationship between the hazard function and the survivor function, described as 
above, an estimate of survivor function can be found. Let the h (t) be the baseline 
hazard function at time t. The general proportional hazard model for the ith individual 
can be written as 
h, (t) = exp(Ji nx1 
)ho (t), 
where x is the explanatory variables and p is the number of explanatory variables. The 
time dependence is described in the baseline population. The A is the unknown 
coefficients of the corresponding explanatory variables and can be estimated using the 
method of maximum partial likelihood, since the likelihood function does not make 
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direct use of the actual censored and uncensored survival times. The maximum 
likelihood estimates of the #-parameters can be achieved by maximising the logarithm 
of the likelihood function, which is accomplished using the Newton-Raphson 
procedure, Collett (1994), which involves the derivative of the log-likelihood function. 
The likelihood function over all death time for the Cox regression is given by 
r eXp(ß x(i)) L(, ß) =rjý exp(/3'x, ) j_l rER(r(, p)) 
where R(t(j) ) is the set of individuals who are alive and uncensored at a time just prior 
to t(j) , called the population at risk, and x(j) 
is the vector of the explanatory variables 
for an individual who is observed to have died at the jth order death time. 
2.2.1 Model validation method for Cox regression 
After a model has been fitted to an observed data set, the adequacy of the fitted model 
needs to be examined. Residuals are one of the commonly used model checking 
procedures which are based on quantities for each individual. A number of residuals 
plots have been adopted in the analysis of survival data. e. g. Cox-Snell residuals, 
Martingale residuals and Deviance residuals. 
The most widely used residuals for the Cox model are the Cox-Snell residuals. It is not 
similar to the residuals in linear regression analysis, however, since Cox-Snell residuals 
are not symmetrically distributed about zero, as they cannot be negative. Alternatively, 
Martingale residuals are derived from the modified Cox-Snell residuals and take values 
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between -- and unity. Grambsch and Fleming (1990) give a comprehensive description 
of the Martingale approach to the analysis of survival data. 
A major weakness of plots based on residuals is that there is no quantitative guideline 
on what constituents a good enough fit. 
2.2.1.1 Residual calculations for Cox regression model 
2.2.1.1.1 Cox-Snell Residual 
The Cox-Snell residual is the most widely used residual in the analysis of survival data 
and is given by Cox and Snell (1968). For the ith individual, i=1,2,..., n, it is given by 
r= exp(/3'x; )Ho(t; ) 
where Ho (t; ) is the estimated cumulative baseline hazard function at time t; . 
If the fitted model is correct, the Cox-Snell residuals have approximately a unit 
ý 
exponential distribution. Let rr, denote the Cox-Snell residuals and S(rý, ) the Kaplan- 
Meier estimate of the survivor function using the residuals 1ý, . If the plot of log{- 
A 
logS(r, )} against log(r, ) is a straight line with unit slope and zero intercept, this 
indicates that the fitted survival model is correct. 
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2.2.1.1.2 Modified Cox-Snell residuals 
Censored data leads to residuals that cannot be regarded on the same footing as 
residuals derived from uncensored data. The Cox-Snell residual needs to be modified 
taking into account the censorship , Collett (1994), chapter 5. 
The Cox-Snell residuals can be modified by the addition of a positive constant A. 
Therefore modified Cox-Snell residuals have the form 
r.,; for uncensored observations, 
r= ci rj +A for censored observations, 
where rc, is the Cox-Snell residual for the ith individual and it is suggested that 0 is 
taken to be unity, this leads to the modified Cox-Snell residuals 
_ 
rci for uncensored observations, 
ci - lrc; +1 for censored observations, 
The modified Cox-Snell residuals can be written as rcr =1-b, + rc1, where 6, is 
a censoring indicator, which takes the value zero if the observed survival of the ith 
individual is censored and unity if it is uncensored. 
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2.2.1.1.3 Martingale residuals 
The modified residuals re', have a mean of unity for uncensored observations and this 
can be relocated to have a mean of zero when an observation is uncensored. In addition, 
when multiplied by -1, this gives new residuals which are known as Martingale 
residuals as 
rMI = b, - rc; 
Fleming and Harrington (1991) gave a comprehensive account of the Martingale 
approach. Martingale residuals take values between -oo and unity, with the residuals 
for censored observations, where 5. = 0, being negative. However, the Martingale 
residuals are not symmetrically distributed about zero. Plots of the residuals against the 
survival time or the rank of the survival time can be used to detect departures from 
proportional hazards. Plots of the residuals against explanatory variables in or out of the 
model indicate whether the variables needs to be included or whether it is necessary to 
transform a variable that has already been included in the model. If the plot does not 
show any particular residuals that stand out from the rest, this confirms that the selected 
model is satisfactory. 
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2.2.1.2 Testing for time dependence of variables 
Validating the model adequacy is important but the proportional hazard assumption 
itself also needs to be examined. If the hazards for the different patient categories were 
not proportional over time, the linear component of the model would become time- 
dependent. The time dependency can be tested by introducing time parameters into the 
model and checking the significance level for interactions between time and the 
covarites, Collett (1994), chapter 5. 
According to the Cox proportional hazards model, the mortality hazard at a time t for 
the ith of n individuals in the study can be written as 
P 
h; (t)=exp 1,8; x;, ho(t), 
j=l 
f 
where xj; is the value of the jth explanatory variable and does not depend on time, x,, 
j=1,2,..., p, for the ith individual, i=1,2,..., n and ho(t) is the baseline hazard function. 
Modifying this model to fit the situation in which some of the explanatory variables are 
time dependent, the Cox regression model becomes 
h1(t) = exp 
ißjx1; (t) ho(t) 
The relative hazard h; (t) /k(t) will therefore, also depends on time. This means that 
the model is no longer a proportional hazards model. 
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2.2.2 Previous studies of analysis using Cox regression 
The Cox proportional hazards model can also be used to predict intervals of time in 
which death is likely to occur for individual patients. ROC curves may be used to 
display the accuracy of prediction with respect to different thresholds, Ohno-Machado 
(1997). Williams (1985) used Cox regression to predict the local or regional recurrence 
of breast cancer after a mastectomy operation. Gore et al (1984) predicted the year of 
death due to breast cancer by defining a threshold which crosses the estimated survival 
function and also discussed the non-proportionality of the hazard functions of the data. 
Magee et al (1996) investigated the prognostic factor for breast cancer recurrence after 
surgery and treatment, using Cox regression. A cubic-linear spline model is proposed by 
Efron (1988) which combins the characteristics of a cubic logistic model and a logistic 
regression model. 
Kay (1977) Stablein et al (1981) and Gill and Schumacher (1987) and Pettitt and Daud 
(1990) highlighted the need to validate the proportional hazard assumption and the use 
of smoothed Schoenfeld (1982) residuals,. The stability of Cox regression can be tested 
by the use of bootstrap, Altman and Andersen, (1989). Alternatively, using the 
bootstrap resampling procedure for model selection in Cox regression, Sauerbrei and 
Schumacher (1992) and Lagakos (1980) proposed a graphical approach to evaluate the 
explanatory variables. Tibshirani (1982) demonstrated the powerful features of Cox 
regression, handling a large number of continuous and categorical prognostic variables, 
resembling the normal linear regression model to the analysis of survival data. Wei 
(1992) proposed the accelerated failure time model, this can be an alternative to Cox 
regression in survival analysis. Schoenfeld (1980), Andersen (1982) and Lin and Wei 
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(1991) tested the goodness of fit of Cox regression and also Arjas (1988) tested it using 
a graphical method. 
Christensen (1987) demonstrated the use of prognostic indexes to separate patients into 
sub groups and rank the groups from high to low risk groups, providing a convenient 
way to visualise the survivorship of new patients. Prentice (1978) proposed the grouped 
data version of the Cox regression to handle large grouped survival data with many tied 
failure times. Prediction of breast cancer recurrence is another area that researchers are 
interested in, Magee et al 1996 and McCready et al (2000) demonstrated the use of Cox 
regression to identify the prognostic factors for breast cancer recurrence. Chen and 
Schnitt (1998) gave a detailed review of available literature on prognostic factors for 
patients with breast cancers l cm and smaller and determined which of these prognostic 
factors might be of value for the identification of low risk patients with auxiliary node 
involvement and/or metastatic disease. Different regression models have been used in 
the analysis of breast cancer survival, Gore et al (1984), in which a few variable 
interaction pairs were found to be significant by these models and the departure from 
proportionality of hazards in breast cancer was confirmed. 
Altman and Lyman (1998) pointed out that many studies are carried out in an effort to 
find the prognostic factors than explain the variation in prognosis of breast cancer 
patients. However the quality of these studies is often in doubt, since a good study 
design and analysis is less favourable for prognostic factor studies than for therapeutic 
trials, some guidelines are then proposed in this paper for conducting and evaluating 
prognostic factor studies to ensure the quality of research is improved. Henderson and 
Patek (1998) also highlighted that the newly discovered prognostic factors for early 
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breast cancer are being used before this information has been properly utilised and little 
information actually helps in making a therapeutic decision in the management of 
individual patients. 
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2.3 Neural Network Model for Survival Analysis 
Neural networks are adaptive non-linear models, and are commonly employed by 
computer scientists and engineers for classification and prediction problems. Some 
studies have applied neural networks to statistical problems with interesting results. 
They have been used in survival analysis to model "mortality" and "time to relapse" and 
claims have been made that they improve upon the accuracy of traditional statistical 
methods. Neural network models for survival extend the proportional hazards model to 
release the linearity and time dependence assumptions and they are usually based on the 
Multi-layer Perceptron network (MLP). Multi-layer networks having either threshold or 
sigmoid activation functions are generally called multi-layer perceptrons. The Bayesian 
neural networks has been proposed by MacKay (1992,1994,1995) using Bayes' 
theorem as a principled framework for regularisation of the MLP. This method included 
a number of important features to over-come over-fitting, also providing a mechanism 
to inhibit the influence of irrelevant input variables in the model, which as known as 
Automatic Relevance Determination (ARD). 
2.3.1 Neural network Model 
Neural networks is the generic title given to universal non-linear function 
approximation algorithms, characterised by a distributed structure with multiple non- 
linear processing units. Certain types of neural network structures simulate the 
associative memory function carried out by networks of neurons in the central nervous 
system and, historically, neural networks were used to help understand the principles of 
memory storage in biological nervous systems, as well as to build computational 
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machines that can carry out complex tasks. The original model of a neuron was 
proposed by McCulloch and Pitts (1943) and consists of a simple threshold activation 
function. Figure(2.3) shows the structure of a MLP with three layers of nodes, namely 
the input, hidden and output layers. Input nodes in the input layer represented the 
explanatory variables. The hidden layer may have many nodes and there may be several 
such layers, depending on the complexity of the problem. One hidden layer is sufficient 
to provide a generic non-linear modelling capability, Bishop (1995). The final layer is 
the output layer which calculates the output of the network, and it too may consist of 
several nodes. 
bias 
Input Hidden 
Figure (2.3): The structure of neural network model. 
Output 
Feed-forward neural networks have one-way connections, from the input layer towards 
the output layer, with no feedback connections permitted. Each connection has an 
adjustable strength, called the connection weight. Each observation consists of a unique 
input signal and the corresponding desired response (target). The network is presented 
with the training sample and the network parameters, weights and bias, are modified so 
as to minimise a global objective function that is intended to match the network's 
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response to the desired response, or target value. The training of the network is repeated 
until the network reaches a steady state, where the changes to the network weights are 
vanishingly small, or until pre-set value of the objective function is achieved, which is 
know as early stopping. 
2.3.2 Activation functions 
The universal approximation property of neural networks is contingent upon the use of 
non-linear activation in the hidden units. These functions take-in the signal received 
from the proceeding layer, which is a linear combination of the network activation there 
and outputs a non-linear function of this scalar variable. 
2.3.2.1 Sigmoid Function 
Sigmoid function is one of the most common form of activation used in the construction 
of artificial neural networks. It is a saturating, monotonic exponential function, given by 
1 
g(a) _ I+ exp(-a) 
where a is the slope parameter, which is a linear sum of the weights and the output of 
previous layer. By varying the parameter a, sigmoid function of different slopes can be 
obtained. A sigmoid function assumes a continuous range of values from 0 to 1. 
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2.3.3 Learning by Error Back Propagation 
The terminology of back propagation was used to describe the mechanism of optimise 
the network weights according to the value of network outputs and the desired target. 
Let there are d input units, M hidden units and c output units. The explanatory variables 
feed into the input layer, through the hidden layer to the output layer, the output of the 
kth output unit can be written as 
Yk =g 
; 
Wkig 
±W 
ji xi 
i=0 
where g(") is transfer function and they both are sigmoid function when working with 
classification problem.. 
`Learning' is the term used to demote updating the network parameters, usually by 
minimising an objective function, E. Gradient descent is one of the simplest network 
optimisation procedures, starting with small random values w°. The parameter w is 
updated at each step z, using slope of the error by an amount 
OW(r) = -rjVE' 
I 
w(T) . 
The parameter Tl is called the learning rate and it is a gain parameter used to stabilise 
the learning process. If it is too large, the algorithm may overshoot the minimum, given 
by VE = 0, leading to an increase in E and possibly into divergent oscillations, which 
may cause a complete breakdown in the algorithm. Or alternatively, the search proceeds 
extremely slowly which is computationally expensive. The learning rate is problem 
dependent and it can be adjusted manually to smooth out convergence. An alternative 
procedure is to use the method of scaled-conjugate gradients (SCG), Mollar (1993b), 
which adopts the principle of line search. SCG estimates the position of the minimum 
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along a series of mutually orthogonal direction. It searches each direction in weight 
space in turn and adjusts the step length automatically along that direction. It is possible 
to choose the step size in the conjugate gradient algorithm without having to evaluate 
the Hessian matrix, which is computationally expensive. 
Scaled conjugate gradient, is an alternative parameter optimisation algorithm, which 
reduces the number of evaluations of error function required for convergence, and 
avoids the need to specify the learning gain. 
2.3.4 Error function 
The error function measures the difference between the network outputs and the desired 
target values. For the classification problem, the cross-entropy error, Hopfield (1987) 
function is commonly used. For a particular class problem, let y be the posterior 
probability of p(C, I x) belonging to the class. The posterior probability of not- 
belonging to the class is then p(C2 I x) =1- y. Then target labeling t for the Class 1 
is 1 and 0 for the class 2. Therefore, the probability of either target value is 
p(t l x) = y` (1- y)'-t 
which defaults to y if t=1, and (1-y) if t=0. For n independent classes, and the form of 
the error function is a penalised log-likelihood 
E=-ý{tk lnyk +(1-tk)In(lyk)}. 
k=1 
For a multi-layer networks, the error function is typically a highly non-linear function of 
the weights, in which many minima and saddlepoints may exist and their gradient in 
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weight space is zero, VE = 0. The minimum that gives the smallest value of the error 
function is called the global minimum, the other minima are called local minima. In 
order to find the minima for the error function, algorithms employ interactive search 
mechanisms through weigh space typically using gradient descent, of the form 
W(r+1) = W() + OW(r) 
for which the error function is guaranteed not to increase. The disadvantage for such 
algorithms is when they reach to a local minimum they may become trapped at 
saddlepoints, where the error function is flat, the algorithms may be stuck for an 
extensive period of time. In practice, different values of the initial weights lead to 
convergence to different local minima. 
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2.3.5 Early stopping and regularisation 
When the algorithms involve a succession of steps and the values calculated within the 
algorithms are based of the previous values, then a stop point needs to be defined. 
Otherwise the network would be over trained, leading to data over-fitting (the networks 
fit the noise as well as the data). However, in reality, the best generalisation 
performance might be obtained at a local minimum, which is not the global minimum of 
the error function. Then the generalisation performance needs to be monitored as a 
function of time during the training, and the training is halted when the optimum 
generalisation performance is reached, early stopping is such a techniques. The error 
generally decreases as a function of the number of iteration during the course of 
training. However, the error with respect to the independent data (validation set), often 
decreases during early training process, but then increases when the network is over 
trained. Training is stopped at the point when the smallest error is achieved with respect 
to the independent data, at which the network is expected to produce the best 
generalisation performance. 
Alternatively, adding a penalty term to the error function, Q, encourages smoother 
network mapping in the form of 
E=E+ vS2 , 
where E is an standard error function and the penalty term S is governed by the 
parameter v the way it influences the form of the error function. When the network 
gives a good and smooth fit to the training data, it gives a small value to the combined 
expression for k (although either of E or vS2 may be individually above their 
minimum possible value). 
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One of the simplest forms of the regulariser is called weight decay, which consists of 
the sum of the squares of all the adaptive weights in the network, not including biases 
S2 =1Iw; . 2. 
Then the cross-entropy error function including the weight decay term is in the form of 
E=-ý{tk lriyk +(1-tk)lri(1-yk) }+2I W? 
k=1 i 
This is called weight decay because in gradient descent it adds a term to the weight 
change, that is 
AO VE=VE+vaw, where 
au 
aW -=-W. 
By itself, this term makes the error reduce exponentially to zero, hence the name of this 
form of regularisation. 
2.4 Bayesian framework for network regularisation 
The Bayesian framework was proposed by McKay (1992 a, b), in part to address the 
issue of regularisation. There are a number of important features offered by a Bayesian 
framework. (1) For regression problem, error bars or confidence intervals can be 
assigned to the estimated outputs. (2) The regularisation coefficients can be 
approximated analytically directly from the training data set. (3) Irrelevant input 
variables, are `softly pruned' using the technique of Automatic Relevance 
Determination (ARD) (1994a, 1995), whereby, a separate regularization coefficient is 
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given to each input node. If a particular coefficient is large, the corresponding weights 
will be forced towards zero, so that the corresponding input variable is of little influence 
upon the network output. 
2.4.1 Distribution of the weights 
Network training was originally described using maximum likelihood techniques, which 
minimise the negative log likelihood error function by attempting to find a single best 
set of values for the network weights. The Bayesian approach treats this differently, by 
considering a probability distribution function over the weight space, p(w). Once the 
data D have been observed, this can then be transformed to posterior distribution p(wID) 
by applying Bayes' theorem 
P(D I w)p(w) 
Pýw I D) = 
p(D) 
The prior probability distribution for the weights was assumed to be Gaussian 
distribution. 
W 
EW =2IIwII2=11 w,, and 2 ; _, 
P(w) = Fýaý- 
1 
W/2 exp(- 2a 
II will), 
, 
wh ere W is the number of the weights and biases in the network and the parameter a is 
the regularisation coefficient, called a hyperparameter, controlling the growth of the 
network weights. 
Chapter 2: Literature Review 
The regularisation produces a penalised log-likelihood cost function, regularised using 
weight decay 
E=-{1[t, 
l 
In y, -F-(1-ln)ln(1-yn)]+ 
ZW? 
n=1 i=1 
2.4.2 Automatic relevance determination 
We assumed the weight distribution as a single Gaussian distribution. But commonly 
the weights fall into a few distinct classes. Weights from different classes should be 
modelled with different prior by assuming a Gaussian prior for each class. Now each 
class has its own hyperparameter C t,. The error function of regularisation becomes 
lnyn +(1-tn)ln(1-yn)]+ 
lI: 
acW`i } 
p=1 
2 
c=1 i=1 
When presenting a large amount of input variables to the network and some of them are 
irrelevant to the network output. Any conventional neural network will fail to set the 
coefficients of these inputs to zero. As a consequence, a finite data will show random 
correlation between inputs and output. 
This problem can be overcome by introducing multiple weight decay constants a,., one 
for each input node. When an input variable corresponds to a large value of a, its value 
will be depressed towards zero, making it an irrelevant input. This helps to avoid 
causing significant overfitting. 
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2.4.3 Marginalisation 
When making an assumption of a Gaussian distribution of the weights, there will be a 
contribution from the Gaussian noise to the network output distribution. For a 
classification problem, the logistic sigmoid function of the form 
Y=g(a)° 
1 
1+ exp(-a) 
is chosen to be the activation function of the output layer since it allows the output to be 
interpreted as the probability P(C1 I x) of an input vector belonging to class x. As a 
consequence of the sigmoid activation function, the network output no longer can be 
approximated linearly by the network weights. Mackay (1992b) introduced a necessary 
modification to the network output, which is marginalisation. 
He assumes the activation a in the sigmoid function is locally a linear function of the 
weights and since the posterior weight distribution is Gaussian, the distribution of a 
will be Gaussian. The mean and variance of this Gaussian distribution can be evaluated 
and gives 
I 
I 
P(a l x, D) =1 exp _(a 
-a MP2 )2 
2s 
i 
where aMP is the most probable value of the activation, given by the usual combination 
of hidden node responses, and the variance s2 is given by s2 (x) = gT A- g, where A 
is the Hessian matrix and g is the gradient. 
It follows that 
P(C, I x, D) =f g(a) p(a I x, D)da. 
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However, this integral is not analytically tractable, so Mackay (1992b) suggests the 
evidence approximation, which involves modulating the activation aMP towards zero, 
corresponding to P(C1 I x, D) = 0.5. Hence suggests 
P(C1 1 x, D) =g 
amp 
1+nS2 is 
2.4.4 Neural Network Model Handling Censored Survival Data (PLANN) 
Hazard function is assumed to be continuous in the proportional hazards model. 
However, in practice, the survival times are usually rounded to the nearest day, month 
or year, therefore tied survival times arise, of which the proportional hazard model is 
unable to handle. Therefore, there is a need for a discrete version of the proportional 
hazards model and it takes the form 
hi (t) 
= 
ho (t) ) 
1-h; (t) 
eXp(, xi 
1- ho (t) 
When the width of the discrete time intervals becomes zero, this model tends to the 
proportional hazard model and also assumes that the censoring has occurred after all the 
deaths at a given time, which resolves the ambiguity of which individuals should be 
included in the risk set at that death time. 
The implementation of this model into a neural network model is straightforward. The 
input layer is the replication of the explanatory variables for all time intervals for 
individuals, in which the subject is observed and including the time as a covariate, since 
the value of fiix, in the algorithm does not change over time. The value of the time 
covariate is taken to be the mid-value of the time interval. Here, only one target variable 
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is assigned to each individual, which is represented by the event indicator d;. This 
indicator only takes value of 1 or 0,1 presented the event of interest happened on that 
subject at that time interval and 0 otherwise. 
The output of the network is posterior probability of death at a given time and the 
estimated survival function over time for i`h individual is given as 
Si (tý )_ rl (1- y(ti)), 
k=1 
where y(t ) is the network output at time j. 
By taking the negative logarithm of the likelihood, we obtain 
P n( ) 
E _-I ýtP, lnyPi +(1-tP, )(1- yPi), 
P=1 +=l 
that is equivalent to the cross-entropy error function. 
This means that the PLANN can be implemented with a standard neural network model 
without any modification to the neural network structure or the calculation algorithms. 
This is proposed by Biganzol (1996). 
Chapter 2: Literature Review 
2.4.5 Previous Neural Networks studies of survival 
Neural network models have been considered as an alternative tools of conventional 
statistical methods for survival analysis. At the early stage of development of neural 
network model for survival data censorship was ignored, Ohno-Machado et al (1995). 
Faraggi and Simon (1995) demonstrated a possible way to compare the traditional 
statistical methods with neural network model. Burke et al (1997) showed that the MLP 
predictions produced a better AUROC than simply assigning patients to the averaged 
survival of the patients in the same TNM stage. However, Brown et at (1997) and 
Radvin and Clark (1992) separately reported that excluding the censored data or treating 
them as missing will incur substantial bias in the estimation of survival. 
Thereby, De Laurentiis et al (1994), Ohno-Machado et al (1995), Faraggi et al (1997) 
and Ripley et al (1998) alternatively proposed different techniques to handle censorship 
within the neural network models, which may require several output nodes to maintain 
the separation between the dependence on time and on the patient specific vector of 
covariates. A more efficient way to represent the time and using only a single output 
node is proposed by Radin et al (1992), De Laurentiis et al (1994) and Liestol et al 
(1994). Biganzoli et al (1998) gave a thoroughly description of the Partial Logistic 
Artificial Neural Network (PLANN) which is a non-linear extension of the discrete 
version of the proportional hazards model. This neural network model of survival has 
proved to be stable in monthly studies over a period of time after treatment and releases 
the proportionality of the hazards assumption and fitting non-linear effects, Laurentiis et 
al (1994), Biganzoli et al, (1998), Lisboa et al, (2000b). 
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In term of the interpretation of analysis results, Radvin et al (1992) and Christensen 
(1987) divided patients into three mortality risk groups, low, medium and high, 
according to their estimated survivorship. While Radvin et al (1992), Tarassenko et al 
(1996) and Ripley and Ripley (1998) used the neural network model to predict the 
recurrence of breast cancer. Groves et al (1999) tested the predictive power of Cox 
regression and the neural networks according to the area under the corresponding ROC 
curves by adding and removing factors from the model, which is an application of 
Acute Lymphoblasitc Leukaemia in children. Mariani et al (1997). The neural network 
model is also used to access prognostic factors for metachronous contralateral breast 
cancer in terms of model predictive ability Lariani et al (1997), in which variable 
interactions are also considered, and also Kappen (1993) investigated the prognostic 
factors for ovarian cancer using multiple neural network models and the Cox regression. 
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3. Breast Cancer Background Information and Data Description 
Within this chapter, a data set that is extensively used in this thesis is described in more 
detail. Two different methods of handling missing data are reported, treating of the 
missing data as a separate attribute and estimating the category using Nominal Logistic 
Regression. Also summarising the criteria that most likely to group the data into two 
subsets representing a low-risk and a high-risk cohort, which are investigated 
separately. 
3.1 Breast Cancer Background Information 
Like other type of cancers, the precise cause of breast cancer and the course of the 
disease are unknown. Moreover, while breast cancer is often perceived as a single 
disease, it is in fact a complex variety of diseases that can begin in different types of 
cells within the breast. It is the leading cause of death in women, whilst it is rarely 
found in men. Britain has one of the highest mortality rates for breast cancer in the 
world and 80% of cases occur in post-menopausal women, the UK Breast Cancer 
Awareness Campaign (1995) claimed. The mortality figures continue to decline due to 
public awareness of the disease and the development of better treatments, but presently 
there is still no way of curing the disease. 
In general, patients are offered four types of treatments, namely surgery, chemotherapy, 
radiotherapy and hormone therapy. Treatments are usually tailored to the individual 
situation, either given alone or in any combination or even in a particular order. 
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3.2 Data Description 
3.2.1 General information of the Data 
The analysis techniques developed and reported in this thesis are applied to a data set 
consisting of 1,616 women breast cancer patients were referred to the Manchester 
Christie Hospital between 1983 to 1989. All patients were treated and underwent 
surgery with at least 5 years follow up and in some cases, as long as 13 years. 
Censorship is an important feature of survival data and cannot be ignored. However, 
Burke (1995) suggested that ignoring censorship would not significantly affect the 
survival of the study. Figure (3.1) displays the survival curves of the variable oestrogen 
including (left) and ignoring (right) censored data and concluded that the effect of 
ignoring censorship is that the calculation of survival is underestimated. Therefore, the 
event of interest in this thesis is `death attributed to breast cancer'. All other causes of 
death and other loss of follow up were regarded as censorship. This is not always clear- 
cut, since death from unrelated cancers need to be identified and are not assigned to `the 
event of interest'. However, in cases of heart attack, for instance it can be difficult to 
make a clear assignment as this may be related to systemic damage caused by prolonged 
chemotherapy. For instance, patients who are surviving beyond the time fame for the 
study are also censored. Since the scope of the study is a five years follow-up, all 
surviving patients are censored at five years if they survived more than 5 years. 
Eighteen categorical variables were collected, which can be summarised into 4 
categories: 1) demographic information, 2) clinical investigations and 3) laboratory test 
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results as well as 4) treatment received. No family history or genetic link was provided, 
Survival Functions 
All Data 
Survival Functions 
Ignoring Censorship 
Oestrogen 
Missing 
8888 
10. 
0-10 
Years 
(a 
Table (3. I) shows a full listing of collected variables. 
.2 0 x 4 6 
Years 
(b 
8 10 12 14 
Figure (3.1): Demonstration of the effect of (a) including and (b) ignoring censorship by 
grouping data using variable oestrogen. 
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Variable Categories Labelling 
1. Menopausal status Pre-menopausal I 
Peri-menopausal 2 
Post-menopausal 3 
Variable Categories Labelling 
2. Age Group 20 - 39 1 
40-59 2 
60+ 3 
Variable Categories Labelling 
3. Predominant site Upper Outer 1 
(The position of tumour Lower Outer 2 
rested in the breast) Upper Inner 3 
Lower Inner 4 
Subareolar 5 
Missing 9 
Variable Categories Labelling 
4. Side Right 1 
Left 2 
Table (3.1): List of variables assessed in each patient. 
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Variable Categories Labelling 
5. Maximum Diameter of <2cm 1 
Tumour (Measured before 2-5cm 2 
tumour removal) 5+cm 3 
Unknown 9 
Variable Categories Labelling 
6. Clinical stage Tumour TO (No Tumour) 0 
(Measurement of tumour TI (Tumour less than 2 cm) I 
after removal) T2 (2-5 cm) 2 
T3 (5+cm) 3 
T4 (any size but fixed on the rib cage) 4 
Variable Categories Labelling 
7. Clinical stage Nodes NO (cannot feel any node or nodes are 
negative) 
0 
Ni (Tumour has been found under 
arm and the same side of breast) 
1 
N2 (Fixed nodes) 2 
N3 (Nodes are further inside the body 
and cannot be removed) 
3 
Table (3.1): List of variables assessed in each patient, continues. 
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Variable Categories Labelling 
8. Metastasis stage MO (negative) 0 
M 1(positive) 1 
Variable Categories Labelling 
9. Clinical stage 0 1 
(also known as the 1 2 
Manchester Stage, it 2 3 
corresponds to different 3 4 
combination of TNM 
staging) 
4 5 
Variable Categories Labelling 
10. Type of Surgery none 1 
Incision Biopsy 2 
Excision Biopsy 3 
Simple Mastectomy 4 
Radical Mastectomy 5 
Wide Local Excision + Ancillary 
Clearance 
6 
Radial Mast + Auxiliary Clearance 7 
Surgery after Neo Adjuvant 
Chemotherapy 
8 
Missing 9 
Table (3.1): List of variables assessed in each patient, continues. 
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Variable Categories Labelling 
11. Adjuvant No 1 
Radiotherapy Yes 2 
Variable Categories Labelling 
12. Adjuvant Treatment none 0 
(Summarised different type CMF 1 
of drugs, including MELPH 2 
chemotherapy and TAM 3 
hormonetherapy) XRAM 4 
OOPH 5 
CYCLO 6 
TAM + CYC 7 
TAM + PRED 8 
ZOLADEX 9 
TAM + ZOL 10 
MEGACE 11 
ZOL + TAM + CMF 12 
NEO ADJ-PRE SURG 13 
CMF + TAM 14 
FAC 15 
Missing 9999 
Table (3.1): List of variables assessed in each patient, continues. 
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Variable Categories Labelling 
13. Histology INF DUCT 1 
INF LOB / LOB IN SITU 2 
IN SITU / MIXED / MEDULLARY / 
UCOID / PAPILLARY / TUBULAR 
/ OTHER MIXED IN SITU 
3 
Missing 9 
Variable Categories Labelling 
14. Number of Nodes 0 1 
Involved (no. of nodes 1-3 2 
have been defined as 4+ 3 
tumour) 98 (too many to count) 4 
Missing 5 
Variable Categories Labelling 
15. Number of Nodes 0-9 1 
Removed (no. of nodes 10-19 2 
have been removed) 20 + 3 
98 (too many to count) 4 
Missing 5 
Table (3.1): List of variables assessed in each patient, continues. 
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Variable Categories Labelling 
16. nodes ratio (number of <=20 % l 
nodes involved / number of 20-30% 2 
nodes removed) 30-60% 3 
60%+ 4 
Missing 5 
Variable Categories Labelling 
17. Pathological Size <2cm 1 
2-5cm 2 
5+ cm 3 
Missing 4 
Variable Categories Labelling 
18. Oestrogen Cytosol 0- 10 (negative) 1 
10+ (Positive) 2 
8888 (Positive) 3 
Missing 4 
Table (3.1): List of variables assessed in each patient, continues. 
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3.2.2 Missing data 
Missing data are inevitable when collecting such a large scale cohort. In this data set, 
some records contain several missing variables, for example: number of nodes involved 
(968 missing), oestrogen (537 missing) and pathological size (452 missing). There are 
only 447 complete cases histories. In some clinical studies, incomplete data was 
discarded completely if the numbers were sufficiently small, Collett (1994). With this 
data set, the majority of missing data cannot be discarded and the cause of missing data 
is unknown. We do not know whether the data are missing at random, missing 
completely at random or missing but informative. 
Two different methods of handling missing data are reported in this thesis. The first, 
missing data was gathered as a separate attribute, which is the simplest method to use. 
The second, missing data was estimated using nominal logistic regression, which is 
appropriate for categorical data. The process of filling in the missing data using nominal 
logistic regression included two parts. Firstly, using the chi-square test, to infer the 
relation of the complete variables and the incomplete variables. Then by determining 
the a subgroup of variables (predictor variables) from the compete variables, which is 
significantly related to the incomplete variables. Secondly, fitting the model (predictor 
variables) using the nominal logistic regression, which produces a set of log ratios of 
the possible categories with respect to the reference category of the incomplete variable. 
From these values, the category value of missing data can be determined. Altogether 4 
incomplete variables were introduced to the nominal logistic regression and table (3.2) 
displays their determined predictor variables and the results are summarised in table 
(3.3). 
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Incomplete variables Predictor variables 
Pathological size Tumour stage, Predominant site, Surgery, Histology, 
Adjuvant Treatment, Node stage 
Number of nodes involved Adjuvant Radiotherapy, Manchester stage, Surgery, 
Adjuvant treatment, predominant site, Histology 
Number of nodes Removed Adjuvant Radiotherapy, Predominant site, Histology, 
Surgery, Metastasis stage 
Oestrogen Age group, Clinical stage, Histology 
Table (3.2): The incomplete variables and their predictor variables. 
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Variables Estimated Category Number of records 
Pathological size 1(<2cros) 106 
2(2-5cms) 278 
3(5+cms) 0 
Number of nodes involved 1(0) 623 
2(1-3) 200 
3(4+) 59 
4(98) 1 
Number of nodes removed 1(0-9) 24 
2(10-19) 1 
3(20+) 0 
4(98) 0 
Oestrogen 0-10 173 
10+ 41 
8888 13 
Table (3.3): Summarised the estimated values for each the incomplete variables. 
Filling-in the missing data allows the whole data set to be used for data analysis. A 
separate category was used for missing data and as consequence none reduced the 
degrees of freedom. If an inappropriate method were used that introduces significant 
bias to the prediction, the analysis would also be inaccurate. So far, there is no definite 
solution available for the categorical missing data; therefore the missing data in this 
data set needed to be handled carefully. Figure (3.2) displays the survival curves of 
pathological size where the missing data are treated as a separate category and filled in 
using the nominal logistic regression, respectively. As a result, more than 60% of the 
missing records were estimated to belong to category 2 and the rest were assigned to 
category 1, which explained the substantial changes that happened to the survival curve 
of category 2. If the data is missing at random, the survival curves should not show 
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substantial changes after being filled-in. However, the substantial difference between 
the two plots in figure (3.2) suggests the missing mechanism may be informative. 
Therefore, the development of survival analysis techniques in this thesis were based on 
the use of a separate category for the missing data, which minimizes the bias introduced 
to the analysis if the filling in method turns out to be inappropriate. 
Survival Functions 
Pathological size - separate category 
Survival Functions 
Pathological size - filled in 
Path Size 
3 
ý 
ý 
' (I, E 
ý 0 
5 years time 
(a) 
5 years time 
(b) 
2 
Figure 3.2: Showing the survival curves of pathological size. (a): Treating the missing 
data as separate category and (b): Filling in the missing data using nominal logistic 
regression. 
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3.3 Splitting data into low and high-risk cohort 
The data analysis in this thesis was based on using the entire data set to predict the year 
of death for individuals and splitting the data into two parts, low-risk and high-risk 
cohorts, which allows precise analysis to be conducted in each cohort. In each cohort, 
an estimated survival function over a fix time period was calculated for each individual, 
thus grouping the patients into prognostic groups in mortality risk order. 
Variables Attributes Value Attributes Value 
Metastasis 0 
Tumour stage 1 2 
Pathological size <2cms 2-5cms 
Node stage 0 1 
Table (3.4): List of variables that contributed to the low-risk cohort separation criteria 
and their values using clinical staging methods. 
The low-risk cohort separate criteria are summarised in table (3.4). The patients in the 
low-risk cohort are at the early stages of the disease. The rest of the records were 
regarded as the high-risk cohort. Therefore the numbers of subjects in the low-risk and 
high-risk cohort are 917 and 633 records, respectively. A total of 66 records were 
discarded owing to the tumour stage being assigned a value of 0, which appears to 
indicate that no tumour is present. The low-risk cohort comprises the majority of 
patients. 
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4 Breast cancer survival analysis using Cox regression 
This chapter investigates two possible survival analysis approaches. After modelling the 
expected survival function for individual patients, there are two ways to interpret the 
results. One is to predict the likelihood of the patient surviving in fixed time intervals, 
the other is to group patients according to prognostic risk. In this chapter, these two 
approaches are compared. 
The second part of this chapter involves partitioning the data into two groups: a low-risk 
cohort and high-risk cohort. For each cohort, prognostic groups are identified by means 
of a ranked mortality risk score of individuals, hence predicting the survivorship over 5 
years or 60 months for each group. The survival prediction based upon Cox regression 
is compared with the observed survivorship which is described by the Kaplan-Meier 
survival estimate. 
4.1 Cox Regression analysis of the whole data set 
4.1.1 Model selection 
One of the important applications of Cox regression (1972) is to identify variables that 
may be of prognostic importance. The approach adopted here for the choice of variable 
to be included in the model is the forward selection stepwise procedure, which was 
applied to the 1,616 records and the analyis is based on a yearly basis over 5 years and 
on a monthly basis over 60 months. Variables were added to the model one at a time 
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and assessed as to whether they significantly made improvements to the goodness of fit 
value to decide which variable to include in the model, Collett (1994). Subjects who 
survived more than 5 years were viewed as being censored at year 6. A total of 8 
variables were selected from the original 18 variables. All of the variables were 
converted to categorical format. For those variables contained large amount of missing 
data, the missing data was treated as a separate category; otherwise, the records were 
removed when the missing data of the variable is significantly small. Therefore, out of 
the 1,616 records, 120 cases were removed, in which 115 records of missing data and 5 
cases of non-positive survival times, leaving 1,496 cases for analysis. From these 1,496 
records, 503 patients died of breast cancer 5 years after surgery and are thus regarded as 
`event cases', with the remaining of 993 records being viewed as censored data. The 
threshold of p-value for the acceptance of a variable is <_ 0.05 and p>0.1 for 
removal which is the default setting of Statistical Package for the Social Sciences 
(SPSS). At each model selection stage, there may be more than one variable made 
significant to the test statistic, only the most significant variable was selected to be 
included in the model. Table (4.1) summarises the variables entering the model together 
with the closest alternative variables at each stage. 
Finally, eight explanatory variables were selected, namely, pathological size, node 
stage, histology, surgery, age group, number of nodes involved and oestrogen. 
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Variables in the model Close alternatives 
f(p value less than 0.05) 
Diameter Manchester Stage, Pathological Size, 
Predominant Site, Age Group, Histology, 
No. of nodes involved, Stage T, Stage M, 
Node Stage, Surgery, Oestrogen 
Diameter + Manchester Stage Oestrogen, Age Group, Histology, 
Menopausal Status, No. of nodes 
involved, Pathological Size, Node Stage, 
Tumour Stage, Surgery 
Diameter + Manchester Stage + Oestrogen No. of nodes Involved, Age Group, 
Histology, 
Pathological Size, Node Stage, Tumour 
Stage, Surgery 
Diameter + Manchester Stage + Oestrogen Pathological Size, Surgery, Age Group, 
+ No. of nodes involved Histology, 
Node Stage, Tumour Stage 
Diameter + Manchester Stage + Oestrogen Age Group, Histology, Node Stage, 
+ No. of nodes involved + Pathological Size Tumour Stage, Surgery 
Manchester Stage + Oestrogen + No. of (Diameter is removed) 
nodes involved + Pathological Size 
Manchester Stage + Oestrogen + No. of Histology, Age Group, Node Stage 
nodes involved + Pathological Size + 
Surgery 
Manchester Stage + Oestrogen + No. of Age Group, Node Stage, Tumour Stage 
nodes involved + Pathological Size + 
Surgery + Histology 
Manchester Stage + Oestrogen + No. of Node Stage, Tumour Stage 
nodes involved + Pathological Size + 
Surgery + Histology + Age Group 
Manchester Stage + Oestrogen + No. of Tumour Stage 
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nodes involved + Pathological Size + 
Surgery + Histology + Age Group + Node 
Stage 
Manchester Stage + Oestrogen + No. of 
nodes involved + Pathological Size + 
Surgery + Histology + Age Group + Node 
Stage + Tumour Stage 
Manchester Stage + Oestrogen + No. of (Tumour Stage is removed) 
nodes involved + Pathological Size + 
Surgery + Histology + Age Group + Node 
Stage 
Table (4.1): Cox regression model selection of the breast cancer data. 
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4.1.2 Model validation 
The Cox-Snell residual calculation is one of the most commonly used methods for 
model validation, Collett (1994). Figure (4.1) displays the modified Cox-Snell residuals 
plot of the entire data. The graph of the residuals is shown an approximately a straight 
line with unit slope and zero intercept, indicating no real evidence against the fitted 
model being adequate. 
Log of Cox-Snell Residual 
Figure (4.1): Plot of Cox-Snell residuals of breast cancer data. It appears as a straight 
line with unit slope and zero intercept, indicating no real evidence against the fitted 
model being adequate. 
The use of Martingale residuals is an alternative model validating method, Collett 
(1994). Figure (4.2) shows plot of the Martingale residuals against the survival time 
while figure (4.3) shows the plot of the Martingale residuals plot against rank of 
survival time. Both of the graphs display no discernible pattern in the residuals over 
time, with only two residuals indicated as potential as outliers, again suggesting no real 
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evidence against the fitted model being adequate. The Martingale residuals can also be 
plotted against the explanatory variables, since the variables are converted into 
categories, therefore, there is not much information that can be extracted in this case. 
Martingale Residuals plot against time 
Survival Times in Days 
Figure (4.2): Martingale residuals versus survival time. There is no pattern in the 
residuals over time, indicating no real evidence against the fitted model being adequate. 
Martingale Residuals Plot against 
Rank of time 
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Figure (4.3): Martingale residuals versus rank of survival time. There is no systematic 
pattern in the residuals over time, indicating no real evidence against the fitted model 
being adequate. 
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4.1.3 Assessing the possibility of time dependency of the explanatory variables 
This section tests the statistical significance in Cox regression of the time dependency 
with the previously selected variables. The -2 log-likelihood, -2 log 
L, value for the 
model without time dependent variables was 7114.600 with 27 degrees of freedom. 
Time dependence was only tested over the first 5 years. The results are summarised in 
table (4.2) below and indicate that none of the variables display true dependent 
behaviour when assessed at the 5% level of significance. With the result, there is no 
evidence to prove that the linear components of the model do not vary with time, 
indicating that the fitted model is adequate, Collett (1994). 
Additional variables -2 1og L Change of Degree of p-value 
added to the model -2 Log Likelihood Freedom 
from the previous 
model 
Time *Age Group 7107.198 7.402 35 0.4939 
Time * Histology 7107.655 6.945 35 0.5426 
Time * Manchester 7095.575 19.025 43 0.2674 
Stage 
Time * Number of 7102.981 11.619 43 0.7698 
Nodes Involved 
Time * Oestrogen 7104.520 10.08 39 0.6089 
Time * Pathological 7103.827 10.773 39 0.5484 
Size 
Time * Node Stage 7097.458 17.141 39 0.143 
Table (4.2): Significant level for assessing the time dependency of the variables. 
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4.2 Survivorship Prediction 
4.2.1 Prediction of 5 years follow-up survivorship using Cox regression 
The survival function of individual patients over a fixed time period can be estimated 
using Cox regression, as Ohno-Machado (1997) has suggested. The estimated survivor 
function for the ith individual at time t is given by S; (t) where 
exp(Q'Xi) 
S1(t) _ [So (t)] 
for t(k) <_ t< t(k+u ,k=1,2,..., r-l of r distinct 
death times, where So (t) is the 
estimated baseline survival function at time t, A is a vector of unknown parameters and 
X, represents the vector of the values of the explanatory variables of the ith individual. 
A5 years survival curve was produced for each of the subjects. The data set was split 
into two parts according to whether the record number was odd or even, to produce the 
training and test set. The /i and the baseline hazard function were estimated using the 
training set, then applied to the test set for performance evaluation. The training and test 
split was in line with the neural network approach, allowing a fair comparison of the 
performance between two methods, where the network parameters are estimated from 
the training set and the model is applied to the test set. Figure (4.5) shows an example 
of the estimated survival curves for 10 patients over the 5 year period. By drawing a 
threshold across the figure at any value on the y-axis, representing the probability of 
survival, the cross points of the threshold and the survival curves were used to predict 
the year of death for each patient, which are reflected on the x-axis. The ROC was used 
to determine the value of threshold giving the most accurate prediction from a range of 
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possible thresholds between 0 and 1. The calculation of the ROC involves the true 
positive rate (sensitivity) divided by the false positive rate (1-specificity). The 
sensitivity and specificity sometimes are called the true positive rate and true negative 
rate, respectively and defined as 
Sensitivity = 
True Positive 
The number of positive cases 
specif iciry = 
\ 0 
N 
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Fig. (4.5): An example of re-estimated survival curves of 10 patients. The horizontal 
line corresponds to a 0.5 probability of survival as the threshold for the prediction of 
survival time after surgery for each patient. 
The definition of true positive in this study is, that the patient is predicted to die of 
breast cancer (positive) within a particular time interval and the patient actually does die 
of breast cancer within the time interval. While the true negative in this study means the 
patient is being predicted not to die of breast cancer within an time interval and the 
patient actually does not die of breast cancer within this time interval. An optimal 
situation would be all of the patients who are to die of breast cancer are predicted to die 
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of breast cancer at the same time interval and all of the patients who are not to die of 
breast cancer are not being predicted as dying of breast cancer at a particular time 
interval for some values of the threshold. This is corresponds to the ROC curve passing 
through the (0,1) point on the graph. 
Figure (4.6) displays the ROC curves of prediction death happening up to respectively 
year 1, year 2, year 3, year 4 and year 5. The calculation is based on taking the 
difference between the survival functions at each time point and the one before, to 
obtain the probabilities of death during each year. The time interval that contained the 
greatest estimated probability of death was interpreted as the predicted year of death. 
For an example, taking 0.5 as the threshold, the actual year of death is the third year and 
if the highest estimated probability of death is in the third year band and is greater or 
equal to 0.5, it is counted as a correct classification. 
The results show that the curves reach sensitivity values above 0.6 only for relatively 
high false negative rates, above 0.2. So this predictive approach is not considered to be 
very informative, and a new approach for the interpretation of survival models is 
proposed. This new approach is based on assigning patients into a prognostic risk 
groups. 
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4.3 Prognostic index and Log-rank test 
The hazard function for the ith individual can be written as 
h; (t) = (p (x, )h (t) , 
where (p(x1) (>0) is a function of the vector of explanatory variables of the ith 
individual that can be interpreted as the relative hazard compared with an individual for 
whom x=0. The function (p (x, ) is conventionally written as exp(irj; ), where 
l7i -Ax1i +P2x2i +... +Apxpi, 
and p is the number of explanatory variables. The quantity 77; is called the prognostic 
index or risk score for the ith individual, Collett (1994). 
The prognostic index provides a score for each subject, and can indicate whether the 
particular patient has a good, intermediate or bad prognosis for survival. Prognostic 
indexes for a given cohort can be ranked and partitioned into prognostic groups, and 
their survival curves displayed for each prognostic group. There are several different 
ways to arrange the prognostic indexes into prognostic groups, by allocating significant 
amount of samples into each group, Christensen (1987). Or alternatively, by observing 
the natural distribution of the indexes from the prognostic indexes plot is also 
considered in this thesis and also use of a well-established statistical method, such as 
the log-rank test. The log-rank test determines, to a given significance level, whether the 
population comprises of two subgroups with different survivorship. The disadvantage of 
the first method is lack of clear guidance about the cut-off point locations. The second 
method is not convincing, when the scores are crowded and leave no gap between 
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groups, as they are difficult to separate by eye. Finally, the log rank test becomes the 
preferred method. 
The log-rank test was proposed by Peto and Peto (1972). In the two group case, the null 
hypothesis is that there is no difference in the prognostic scores of the individuals in 
two groups. The tenability of this hypothesis is tested by considering the difference 
between the observed number of surviving individuals in the two groups at each time 
points and the number expected under the null hypothesis. 
Let d, j and 
d2j be the number of deaths at t(j), j=1,2,... r, in group 1 and group 2, 
respectively, r is the number of distinct death times, and the n, j and n2i be the number 
of individuals at risk at time t(j) in group 1 and group 2, respectively. Therefore the 
expected number of individuals e,; who die at time t(j) in group 1 is given by 
j, e, j = njd j 
In 
where dj =dij +d2j and nj =n, j +n2j. 
The overall measure of the deviation of the observed values of d, j from their expected 
values is calculated by summation of the differences d, j - eij over the total number of 
time intervals, r, in the two groups. The test statistic is given by 
r 
UL - (d1 -ej) with the variance of d, j being given by 
j=l 
n, jn2j(nj - 
dj) r 
v, j = 2( , so that the variance of 
UL is var(UL Ivii = VL . nj nj -1) j_, 
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Note that UL has an approximate normal distribution when the number of death times 
is not too small, Collett (1994), so that Ho: UL / VL has approximately the standard 
normal distribution and can be written as 
UL 
- N(0,1) . VL 
2 
In addition, note that 
vL 
_ X; , where 
X1 denotes the chi-squared distribution with 
L 
one degree of freedom. 
The larger the value of the statistic WL = Uý /VL , the greater the evidence against the 
null hypothesis. A 5% significance level is used here. 
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4.4 Low-risk cohort analysis of Cox regression 
4.4.1 Model selection 
A new variable nodes ratio was considered at this point. This is the ratio of the number 
of positive nodes to the number of nodes removed. The number of positive nodes has 
already been selected as an important variable, see section (4.1.1). Considering that two 
patients with same number of positive nodes may have different prognoses since 
clinicians tend to have different prognoses depending upon the total number of nodes 
that have been removed. For example, a patient who has 5 positive nodes out of 5 nodes 
removed is more severely affected than a patient who has 5 positive nodes out of 30 
nodes removed. The nodes ratio variable was designed to take into account this 
consideration. 
By applying the low-risk cohort selection criteria described in section (3.3), a total of 
917 cases were selected. A forward stepwise elimination model selection was 
performed once again as described in section (4.1.1). However, four variables were 
excluded from the pool of variables in order to identify the prognostic factors which 
provide information on the survivorship of the patient regardless of treatment. The four 
variables are namely treatment, surgery, oestrogen and adjuvant radiotherapy. 
Oestrogen is a measurement of female hormone, and the remaining three variables are 
decided by the doctors according to the symptoms of the patients. The selected variables 
are node stage, nodes ratio, histology and pathological size. Akaike's information 
criterion (AIC), Akaike (1973), was also employed to measure and establish the 
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significance of the value of -2 log -likelihood, - 2log L, on adding new terms into a 
model or deleting existing terms from the model. The AIC statistic is 
AIC = -21og L+ aq, 
in which q is the number of unknown parameters in the model and a is a 
predetermined constant that specifies the weighting between fit accuracy, which is 
measured by -2 log L, and model complexity and GY =3 is recommended for general 
use. The final model chosen was that with the smallest value of the AIC, and in fact, the 
final model contained 4 variables from the original 6, namely histology, pathological 
size, node stage and nodes ratio. Vonta et al (1998) also used the AIC test statistic to 
select the best subset of variables to be included in the final Cox model and found that 
the lymph nodes, tumour size (pathological size) and grade (tumour stage) have 
significant impact on the survival times of breast cancer as our model showed. The 
details are given in table (4.3). 
Model selected from SPSS -2 1og L 
Parameters 
in model 
AIC 
Node stage 3734.798 2 3740.798 
Node stage + Nodes ratio 3700.972 7 3724.872 
Node stage + Nodes ratio + Histology 3680.338 10 3710.338 
Node stage + Nodes ratio + Histology + 
Pathological size 
3669.689 12 3705.689 
Node stage + Nodes ratio + histology + Path 
Pathological size + Age group 
3661.818 15 3706.818 
Node stage + Nodes ratio + Histology + Path 
Pathological size + Age group + Diameter 
3651.835 19 3708.835 
Table (4.3): The AIC measurement for each step of the variable selection process for 
the low-risk cohort. 
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4.4.2 Natural distribution of the prognostic groups of the low-risk cohort 
The low-risk cohort was split into training (458 records) and test sets (459 records), 
based upon the odd or even record number. A5 years analysis was again conducted, 
therefore all patients who survived more than 5 years were viewed as being censored at 
year 6. The training and test split process is in line with neural networks analysis for a 
fair modelling methods comparison. By considering the natural distribution of the 
prognostic indexes, the test set data were partitioned into 7 prognostic groups as 
illustrated in figure (4.7). The Cox regression and the Kaplan-Meier estimated survival 
curves for each of the prognostic groups are displayed in figure (4.8). 
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Figure (4.7): Each band represents one prognostic group, labeled from I to 7, they are 
aggregated by observing the natural grouping behaviour of prognostic indexes. 
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Figure (4.8): (a) The predicted survivorship for each of prognostic group using Cox 
regression in the low-risk cohort and (b) the corresponding Kaplan-Meier estimate of 
the survivor function, which represents the observed survivorship for each group. The 
results show the estimated performance is acceptable in general by comparing the two 
graphs, except for groups 2 and 6 which show an over and under estimation of the 
survivorship of the groups, respectively. 
When comparing the estimated survival curves using Cox regression with the Kaplan- 
Meier estimated survivor functions, which are used to described the observed 
probability of survival, the accuracy of the survival estimation was varied over the 
prognostic groups. The smaller the value of the prognostic index, the greater the 
survival probability of the subject/group will be. In addition the prognostic index has 
been arranged in mortality risk order, so that the prognostic group 1 to 7 are in the order 
from the highest to the lowest degree of survival. However, the results show that some 
of the curves overlapped or crossed. This suggests that some of the prognostic groups 
potentially could be combined. 
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The natural grouping approach becomes inaccurate when the separation of the 
prognostic groups is not clear. We thus consider an alternative grouping method and 
adopted the log-rank test for the partition of the data into prognostic groups. 
4.4.3 Partitioning the low-risk Cohort into prognostic groups using Log-rank test 
The log-rank test, described in section (4.3), was adopted to replace the visualisation 
grouping method, in which the survival curves of two groups is compared by measuring 
the significance level arising out of a test of the equality of the two survivor functions. 
The process begins with choosing the cut-off point from the lowest prognostic index 
value to the highest. The log-rank test was performed separately at each cut-off point; 
therefore a set of p-values was obtained. The optimal cut-off was chosen at the cut-off 
point with the highest p-value and the group was split only if this is significant at least 
at the 5% level. A subset of patients, whose prognostic index was greater than the 
optimal cut-off point, were removed from the data and regarded as one prognostic 
group. The whole process was repeated until no more prognostic groups could be 
defined. 
Figure (4.9) displays the four groups obtained via the above log-rank test based 
approach. The study was conducted with monthly time resolution over 60 months. The 
performance measure was no longer only applied to the test set, but a 5-fold cross 
validation was introduced. Furthermore, 95% confidence interval bands were also 
included with the Kaplan-Meier curves, as this helps to identify the separation between 
prognostic groups, assessing the uncertainty of the data as displayed in figure (4.10). By 
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displaying the variable profiles of each prognostic group as shown in figure (4.11), the 
contribution of each variable is monitored, hence illustrating which variables play an 
important role in each prognostic group. 
Note that the number of prognostic groups obtained using this approach is fewer that the 
number obtained using the previous approach and none of the survival curves crossed 
over or overlapped. The log-rank test is a well-developed method for survival curves 
comparison. The results indicate that it is better than visualisation grouping method, the 
survival curves are well separated and also the estimated survival rate was improved for 
each group. 
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Figure (4.9): A total of 4 prognostic groups were aggregated by the log-rank test and 
labelled from I to 4, contained 127,189,487 and 114 patients, respectively. 
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4.5 Cox regression for the high-risk cohort 
4.5.1 Model selection 
A total of 633 records were left after the low-risk cohort was removed from the design 
data set, which are regarded as a high-risk cohort. The model selection procedure was 
repeated with the AIC criterion, as described in section (4.1.1). The selected model 
comprised the variables menopausal status, node stage, pathological size, clinical 
staging and nodes ratio. Node stage, pathological size and nodes ratio are again being 
selected as for the low-risk cohort. The details of each stage in the model selection 
process and the value of the respective AIC values are displayed in table (4.4). 
Vaiables in the model -2 log 
L Degrees of 
freedom 
AIC 
value 
Clinical stage 3805.973 3 3814.973 
Clinical stage, Pathological size 3789.091 6 3807.091 
Clinical stage, Pathological size, nodes ratio 3773.244 10 3803.244 
Clinical stage, Pathological size, nodes ratio, 
Menopausal status 
3764.722 12 3800.722 
Clinical stage, Pathological size, nodes ratio, 
Menopausal status, Node stage 
3754.329 15 3799.329 
Table (4.4): The AIC value of each variable during the model selection process for the 
high-risk cohort. 
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4.5.2 Applying the selected model to the high-risk cohort 
The analysis was carried out on a monthly bases for 60 months using 3-fold cross 
validation. Again the log-rank test was adopted to identify the prognostic groups. The 
results are summarised in the order of figures (4.12) to (4.14). Figure (4.12) displays the 
log-rank test aggregated prognostic groups from the prognostic indexes, and figure 
(4.13) the estimated survival curves over 60 months for each prognostic group and the 
Kaplan-Meier estimate of the survivor functions. The variables profile for each 
prognostic group is illustrated in figure (4.14). 
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Figure (4.12): The 3 groups obtained via the log-rank test by means of prognostic 
indexes and labelled from I to 3 as illustrated. Their sample size is displayed next to 
their group labelling. Group 2 contained almost 45% of the patients in the high risk 
group. 
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Figure (4.13) (a): The Cox regression estimated survival curve over 60 months for 3 
prognostic groups and labelled as pi 1, pi2, and pi3 from top to bottom. Right: Their 
corresponding Kaplan-Meier estimated survival curves. The curves are well separated 
on the graph and their Cox survival estimations are within their confidence hands when 
compared with the observed survival curves. The small confidence interval hands 
suggests that the variance within each group is small. 
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Figure (4.14): A display of the variable profiles within each of the prognostic groups to 
observe the category shifting behaviour of each variable. The display shows that (except 
the menopausal status) the variables display a different degree of the category shifting 
movement over the prognostic groups. The category 4 of pathological size represents 
the missing data of the variable. 
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The display of the prognostic indexes in figure (4.12) has demonstrated again the 
importance of the log-rank test in this study by providing an objective criterion to assign 
patients into prognostic risk groups. Figure (4.13) also suggests that the performance of 
the Cox regression approach in predicting the mean actual survival for each group is 
acceptable. The major variables dominating the prognostic group I and 2 are the node 
stage and clinical stage, with the node stage changing from category 0 to I while the 
clinical stage shifts from category 1 to either categories 2 or 3. The other variables also 
show some degrees of category shifting behaviour as pathological size shifts from 
category 1 to 2 which corresponds to <2cms and 2-5cms respectively. This shifting 
sequence is continued into prognostic group 3. 
The results show that the survival probability of prognostic group (pi) 1 after 5 years is 
0.8. A question raises `Does this group truly belong to the high-risk cohort? ' The 
pathological size was one of the criteria for defining the low- and high-risk cohorts, but 
itself also contained missing data on 414 out of 1,530 records. As these 414 records did 
not have confirmed small tumour diameter, they were left in the high-risk cohort. 
However, 203 records partially fit into the criteria of low-risk cohort on the basis of 
tumour stage, in which subsets of 120,75 and 8 records were allocated to the prognostic 
group 1,2 and 3 respectively. These records probably do belong to the low-risk cohort 
and it is interesting that they were identified as low-risk even using pathological size, 
coding missing value as a separate attribute. The prognostic group I in the high-risk 
cohort may correspond to the prognostic group 2 and 3 in low-risk cohort. Removing 
the 120 records from prognostic group 1 of 171 records, leaves only 51 records, they 
might be the true members of prognostic group 1. The subset of 75 records may also 
correspond to the prognostic group 4 in the low-risk cohort where the survival 
probability was 0.5. 
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The results have demonstrated that the approach of predicting the year of death for 
individuals is not informative. On the other hand, the second approach produced some 
interesting results, which involved defining prognostic groups and estimating group 
survivorship. 
After completing the analysis for the low-risk and high-risk cohorts using Cox 
regression, one further interesting point was found. The motivation behind the 
separation of the data into two cohorts was to try to understand the survivorship of the 
disease and to enable a precise analysis of each cohort to be made. The above analysis 
has shown that there was no clean cut-off point for separating the data between low- 
and high- risk cohorts. There is a group of patients which overlaps the two cohorts. 
4.6 Discussion and Conclusion of Cox regression analysis of the breast cancer data 
Two analytic approaches are illustrated in this chapter, prediction of `year of death' and 
survival prediction for prognostic groups. The unsuccessful attempt of estimating the 
likely year of death is possibly caused by the large amount of censored data. 
The second approach, in which the low- and high-risk cohorts are both further divided 
into distinct prognostic groups, gives more promising results. The Cox regression 
predicted survival for the prognostic groups agrees well with the corresponding Kaplan- 
Meier estimated survivor function, and falls within the confidence bands. This is 
especially true when the log-rank test is used to partition patients into prognostic 
groups. 
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The fact that the pathological size variable contained many missing values in the high- 
risk cohort caused confusion in the cohort assignment, where the records containing 
missing values of pathological size were allocated into the high-risk cohort, since 
pathological size is one of the main separation criteria. The identified prognostic group 
1 in the high-risk cohort appears to be a high survival group and contains a substantial 
number of patients. Most of the patients in this group have the pathological size labelled 
missing. It is possible that they are the patients really showing a high survivorship from 
the high-risk cohort or it is the confusion caused by the number of clinical data 
separation criteria containing missing data. Missing data cannot be avoided when 
collecting a large amount of data and there is no definite solution or method for 
handling categorical missing data without the potential for introducing bias into the 
analysis. The data separation criteria may need to be redesigned to include verifying 
incomplete variables against likely indictor, for example, using tumour stage when 
pathological size is unavailable. 
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5. Neural networks breast cancer Application 
This chapter summarises the results of two survival analysis approaches using neural 
networks. Due to the restrictions of the network structure, censorship is not considered 
at the first approach. In this approach, the probability of death 5 years after surgery is 
calculated for individuals and presents with the ROC curve, then benchmarks with the 
Cox regression of the same approach. 
In the second approach, the role of analysis has changed. A5 years survival function is 
predicted for individuals, in which the neural networks model is modified to be capable 
of handling censorship, by implementing a partial logistic model. Also, the data are 
divided into low- and high-risk cohorts. In each cohort, patients are allocated into 
mortality risk groups, and the corresponding survival function is calculated by the 
average of the 5 years survivorship prediction of the group. Hence, the accuracy of the 
prediction is assessed by the Kaplan-Meier estimation of survival from the observations 
for that group. Moreover, two different neural network approaches are adopted, 
including the most commonly used MLP trained by back-error propagation and the 
neural network trained with a Bayesian framework. In the Bayesian neural network 
approach, the results report substantial bias introduced to the network estimation 
because of the skewness of the distribution of target values, which is solved by 
marginalising the outputs to the averaged hazard of the data. This chapter also 
introduces the more advanced automatic relevant determination (ARD) technique which 
carries out soft pruning of the model. 
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5.1 Prediction of 5 years survivorship using the MLP network 
Neural networks are non-linear modelling methods, with successful applications in 
many fields. Medical analysis is one of the fields that adopts this method, in which the 
probability of a disease occurrence is frequently the variable of interest. 
In order to calculate the probability of death 5 years after surgery for breast cancer 
patients, a5 year survival curve for individuals is required. Gore et al (1984) proposed 
using the cross point of a threshold that crosses the survival curve to predict the year of 
death for individual patients. Two different network frameworks are used, the ordinary 
MLP and the neural network trained with Bayesian framework, the details are given in 
section (5.1.1) and (5.1.2), respectively. 
For each neural network, the 1376 records were split into two groups of 688 records 
each, selection was dependent on the odd or even record number. One set was used to 
train the network for parameter generalisation and the other set was used for testing. 
The number of patients who survived beyond 5 years in the training set and test set is 
437 and 436 respectively. The rest of the records are spread over the other 5 years of 
classes. The outputs can be interpreted as the probability of death at a particular time 
interval and the cumulative probability of death for ith individual is given as 
r 
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for t=1,2,..., k where k is number of time intervals, n, is the network output of each 
time intervals and h; (t) is the cumulative probability of death at particular time 
interval. Figure (5.1) shows an example of estimated cumulative probability of death of 
a patient over the first 5 years and beyond 5 years. To predict the year of death for this 
patient, a threshold is identified for the y-axis and the predicted year of death for an 
individual patient is identified by the cross-over between the cumulative probability of 
death and the pre-specified threshold. 
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Figure (5.1): An example of neural network estimated cumulative probability of death 
of an individual patient over the first 5 years and beyond 5 years. Using 0.5 as the 
threshold to predict the year of death, it is predicted the death is most likely happened in 
year 2. 
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5.1.1 MLP network with early -stopping 
Six different MLP networks are employed, each network represents one-year interval of 
5 years and beyond 5 years. For the patients who survived in that time interval, the 
target is labeled with 0, or I for death of breast cancer. The network consisted of 35 
input nodes, one hidden layer of 8 hidden nodes, which has been tested for convergence 
and performance, and 1 output node. The 35 binary input nodes were transformed from 
the 8 Cox regression selected variables, reported in section (4.1.1). Since censorship 
was not considered at this stage, the patients who survived beyond 5 years were 
considered to be dead after 5 years and those censored before 5 years are discarded. 
Early-stopping was employed to overcome the over-fitting problem, where the network 
training was stopped when the smallest error was archived with respect to new data. 
During a typical training session, the training data error generally decreases as a 
function of the number of iterations in the algorithm, whereas the test error first reduces 
than slowly increases, achieving a minimum value where generalisation is optimal. 
Gradient descent was the adopted parameter optimisation algorithm for its simplicity 
and efficacy and the sigmoid function was the chosen activation function for the 
network of which restricted the output value to be between 0 and 1, and can be 
interpreted as probability of death. Each network was trained for 120 iterations. 
The calculation required for ROC curves was discussed in section (4.2.1), which 
involved sensitivity and specificity. The network output can be read as predicting an 
independent probability of death for each year, same approach as the Cox regression in 
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section (4.2). Figure (5.2) displays the ROC curves for each year and the results are 
similar to those obtained with Cox regression, and inconclusive. 
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Fig. (5.2): The ROC curves of independent probability of death. 
5.1.2 Bayesian Approach 
We began with the consideration of the architecture of neural networks, number of 
layers, number of hidden nodes and choice of activation function. In the conventional 
maximum likelihood approach, a single `best' set of weight values is determined by 
minimising a suitable error function. By contrast, the Bayesian approach considers a 
probability distribution function over weight space and this can be obtained by 
calculating the posterior probability distribution given some prior distribution. Once the 
data has been observed, the prior distribution can be converted to a posterior 
distribution through the use of Bayes' theorem. The posterior distribution can then be 
used to evaluate the predictions of the trained network for new inputs, Bishop (1995), 
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chapter 10. Aston's Netlab software was used, this software is specially designed for 
neural network classification problems. 
In the Bayesian model with automatic relevance determination (ARD), there were 38 
distinct weights decay parameters, one for the fan-out weights fan from each input 
node; one for the bias of hidden nodes; one for the output node weights and the last one 
for the output node bias. The network was trained until all parameters had converged. 
Figure (5.3) is the ROC curves using the neural network trained with Bayesian 
framework to predict the year of death of breast cancer for 5 years and beyond 5 years. 
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Figure (5.3): The ROC curves of Bayesian regularised neural network for year I, year 2, 
year 3, year 4, year 5 and beyond year 5. 
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5.1.3 Summary of death year prediction with a neural network 
By comparing the results of the Bayesian model and the conventional MLP over the 
independent probability of death method, the Bayesian model shows a better 
performance on year 2,3 and 4, while the second shows better performance of 
prediction in the first year after surgery. There is no apparent difference between the 
performance of methods for predicting death beyond year 5. 
The results also suggests that the neural networks Bayesian approach can perform as 
well as the Cox regression, figure (4.6). The neural networks perform better in the 
prediction of death for all time intervals except year 1, which the Cox regression shows 
better prediction performance, concluding that neural networks are marginally better in 
long-term outcome prediction. However, none of the results can be considered as being 
significant for clinical use and some other studies have highlighted that omitting 
censorship may bias the result, Brown et al (1997) and Radvin and Clark (1992), 
therefore this approach was ended. 
Although the results show the neural network performance is marginally better than the 
Cox regression, both methods failed to produce interpretable results. At this stage, 
censorship is not considered. Dealing with censorship in the development of neural 
network model for survival analysis is essential. The Partial Logistic Artificial Neural 
Networks (PLANN) model, Biganzoli (1996), was identified from the literature review 
to be preferred solutions to handle censorship. The application of PLANN model to the 
breast cancer data is summarised in the following sections. 
Chapter 5: Neural Network Breast Cancer Application 
5.2 Neural network modelling of censored data 
The new approach aims to accurately estimate the cumulative probability of survival for 
each individual up to a maximum time period, putting all the subjects are partitioned 
into prognostic groups via the use of prognostic indexes. A predicted mean survivorship 
for each prognostic group can then be evaluated. Throughout this chapter, all survival 
analyses were based on 5 years or equivalently 60 months. 
5.2.1 Defining a prognostic index in neural network model 
Prior to identifying distinct risk groups, it is necessary to rank all of the patients in order 
of mortality risk. This ranking uses prognostic indexes that are defined separately for 
both the Cox regression and the PLANN model. 
In neural networks, the equivalent of the Aix exponent used in Cox rgression is obtained 
by treating the Multi-Layer Perceptron (MLP) structure as a non-linear extension of 
logistic regression, and taking the logit of the hazard prediction. However, as this is 
time-dependent, a cumulative index is obtained by averaging it over the time-span of 
the study, to give 
T 
11og it(y) 
PINN - =1 T, 
where T is the number of time intervals (Lisboa et al 2000) 
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5.2.2 The preliminary test of applying the PLANN model to the neural networks using 
the low-risk cohort 
A conventional MLP network was first adopted to implement the PLANN model. The 
data set used is the low-risk cohort which was split from the data following the criteria 
given in section (3.3). The training set contained 458 samples with 459 samples in the 
test set according the odd and even record number. The input variables of the networks 
were the variables that Cox regression selected namely; node stage, histology, nodes 
ratio and pathological size in section (4.4.1). These variables were then transformed 
into 12 binary attributes, together with the time covariate, formed the input layer of the 
network. Hence, the value of the time covariate was the mid-point of each time interval. 
Due to the characteristic of the PLANN model, records in the training set were 
replicated extensively for each time interval until the patients dropped out from the 
study. The target label for an observed time interval was 0 where the patient was 
observed alive and 1 when the event of interest occurs in that time interval. Therefore 
no sample replication and target labeling was allocated to the subjects after they were 
dropped out from the study. Unlike the training set, all subjects in the test set were 
replicated for all time intervals. Only one output node was needed for this model, which 
represented the conditional probabilities of death from breast cancer in a time interval, 
therefore the model predicts the hazard mortality. 
The networks contained a single hidden layer of 12 hidden nodes and adopted the scaled 
conjugate gradient (SCG) algorithm as the parameter optimisation method replacing the 
gradient descent algorithm. This algorithm is claimed to be faster to reach convergence 
and has fewer pre-set parameters, Bishop (1995). Different values of weight decay 
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parameter have been tested, finally 0.075 was chosen for the wideness range of 
prognostic indexes and also better separation and grouping of mortality risk groups. In 
order to overcome the over-fitting problem, early stopping was adopted. The network 
was trained with only 30 loops. 
5.2.2.1 Result Implementation 
Since each subject in the test set was replicated 6 times with a different value for the 
time covariate for a5 years study, therefore each subject is associated with 6 output 
values and 6 prognostic indexes, and each output value was independent of the others. 
They are recorded independently after training, the 6 prognostic indexes are averaged to 
represent the risk score (prognostic index) of an individual and the 6 output values were 
transformed to cumulative probability of survival function over 5 years and the 
calculation for ith individual is 
Si (t1) _ At <_ tk It> tk_I) , where j is the number of time intervals. 
k=1 
Hence, 
Si (tj) _ (1- y(tk )) , Yk is the network output at time k. 
k=l 
By plotting a histogram of the prognostic indexes of all subjects in the test set, the 
indexes are naturally gathered into a number of small groups, which can be identified 
by eye, as shown in figure (5.4). Each band represents one prognostic group, 5 groups 
were identified in this case. The network predicted mean survivorship for each 
prognostic group together with the corresponding Kaplan-Meier estimate of the survivor 
functions including 95% confidence interval are displayed in figure (5.5). The Kaplan- 
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Meier estimated survivorship function is used to describe the observed survivorship for 
each prognostic group, which allows assessing the accuracy of network prediction for 
prognostic groups. 
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Figure (5.4): Subjects were divided into five mortality risk groups by the eyeballing 
method from the ranked prognostic indexes 
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Figure (5.5): The neural network SCG approach predicted survivorship over 5 years for 
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survivor functions. In general, the performance of the neural network survival 
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The results show that some of the survival curves are close together and their 
confidence intervals actually overlapped, suggesting that some of the prognostic groups 
can be potentially combined, i. e. group I and 2, group 3 and 4. The combined results 
are displayed in figure (5.5), finally 3 prognostic groups are left, each contains 194,221 
and 44 subjects, respectively. The confidence interval bands for group 1 and 2 are clear, 
with no serious over-lapping, and also the accuracy of the estimated survivorship for 
prognostic groups compared with that observed has been improved. The result after 
combining specific prognostic groups has given strong statements that the neural 
network model is capable of handling censored data, and give accurate survival 
predictions with small confidence intervals. 
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Figure (5.5): The predicted survivorship for the 3 prognostic groups after combining 
some of the groups from figure (5.4) and the corresponding Kaplan-Meier estimate of 
the survivor functions. The results display better prognostic group separation and 
survival estimate accuracy. 
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5.2.2.2 Discussion of the first neural network model handling censored survival data 
The Cox regression, is the most commonly used conventional statistical tool for 
survival analysis, and its the high popularity is due to commercial availability and its 
robustness and ease of interpretation. Whereas, the neural network model produced 
some interesting results which are different from those of the Cox regression. Using the 
same approach, with fewer prognostic groups, and more accurate survival estimation for 
prognostic groups. One disadvantage of the neural network approach is the time spent 
on obtaining the optimal network structure, the correct number of hidden nodes and the 
weight decay value. Even though a good network design is not always guaranteed the 
result will be better than the conventional statistical method, it should be at least as 
good as it. So far, it is only a preliminary test of the potential use of neural networks for 
censored survival data and the result has given a positive agreement. The next stage is 
to repeat the SCG approach but implement it with the 5-fold cross validation method, 
then applying the PLANN model to the neural networks trained with a Bayesian 
framework, which is an alternative approach to the network weights optimisation 
method. 
5.2.3 SCG approach of low-risk cohort using cross validation procedure 
The SCG training and test split approach has suggested that the neural network PLANN 
model is capable of handling censored survival data. The analysis was repeated once 
again using the SCG approach but trained with a 5-fold cross validation procedure, 
which allowed better understanding og the nature of this data in general. The results are 
summarised in figure (5.6) - (5.7) as in sequence of, dividing mortality risk groups by 
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eye judgement, the network predicted survivorship for each prognostic group together 
with the corresponding Kaplan-Meier estimate of the survivor functions. 
90 
E30 
70 
60 
" 50 
-40 
30 
20 
SCG, cancer data, mid-point of real time, 12 hidden nodes 
I 2 3 4 5 
L -5 -4.5 -4 -3.5 -3 1 -Oh 
PI value 
Figure (5.6): The five partitioned mortality risk groups using visualisation grouping 
method from ranked prognostic indexes which is calculated by the network over 5 fold 
cross validation sets. 
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Figure (5.7): The neural network predicted mean survivorship for each of the prognostic 
groups and the corresponding Kaplan-Meier estimate of the survivor functions. The 
curves are nicely separated and the survival estimation gives a good agreement. 
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The result shows that the five prognostic groups are nicely separated. Moreover, the 
prognostic group 3 and 4 have the potential to be combined and more interestingly, 
prognostic group 1 shows a 100% of survival chance over 5 years. The accuracy of the 
estimated survival has not been improved by the cross-validation method but the 
confidence intervals for each prognostic group are narrower than the training and test 
split approach. 
The SCG approach has already produced some useful results. The next step will test the 
PLANN model with the neural network Bayesian approach, since it overcomes the 
over-fitting naturally and the ARD technique can be added on to tune down the 
irrelevant input variables from affecting the network calculation. 
5.3 Bayesian framework for the PLANN model 
The evidence approximation to the Bayesian neural network is an alternative parameter 
regularisation framework. This approach uses a hyperparameter that controls the 
strength of weight decay. Only a single value of hyper-parameter a is considered at this 
stage, in which all input variables share same value of alpha. Multiple alpha values will 
be considered later in the ARD approach, reported in section (5.4). The input variables 
were those selected by the Cox regression which allows comparison over different 
weight optimisation approach. A single layer of eighteen hidden nodes was adopted for 
better network estimates, wider range of prognostic indexes and better mortality group 
separation. One output node was used. The analysis was completed with a 5-fold cross 
validation and yearly bases of 5 years. The result of prognostic group partitioning was 
that the network predicted survivorship for prognostic groups and the corresponding 
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Kaplan-Meier estimate of the survivor functions are summarised in the figure (5.8) - 
(5.9), respectively. 
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Figure (5.8): The neural network Bayesian approach evaluated prognostic indexes of 
917 low-risk cohort data, 5 prognostic groups were partitioned by visualisation 
grouping method. 
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the corresponding Kaplan-Meier estimate of the survivor functions. 
Figure (5.9) shows that the survival curves of 5 prognostic groups are nicely separated 
between 0.97 to 0.3 at year 5. The majority of patients are partitioned into groups 2 and 
3. The SCG approach aggregated highest survival group which showed a 100% 
survivorship has disappeared, the predicted survival of the newly formed prognostic 
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survivorship has disappeared, the predicted survival of the newly formed prognostic 
group 1 is 0.97, still a very high survival group. In term of the accuracy of survival 
prediction, the Bayesian approach is marginally better than the SCG approach in 
general. 
The result is comparable with the conventional statistical tools, the Cox regression in 
this study. Another special feature of the Bayesian framework is the use of the ARD 
technique where the input variables that are least relevant to class differentiation can be 
determined. Although the input variables were selected by Cox regression and have 
been proved to be effective in prediction, neural networks may act differently on these 
variables since they are non-linear methods unlike linear Cox regression. 
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5.4 The PLANN model of Bayesian framework using ARD 
The ARD technique was based on the use of a separate hyper-parameter for each input 
variable. Each alpha controls the optimisation of the network weights that fan out from 
the each input variable. The assumption is that irrelevant, or noisy covariates, develop 
large hyperparameter values that penalise the objective function, E, driving down the 
values of the regression coefficients (or weights) associated with them. Therefore, the 
bigger value of the alpha, the smaller value of the corresponding weights to be. In other 
word, the alpha value is a measurement that determines the irrelevant input variables 
and minimises their influence towards the network output. This is called soft pruning. 
The network input variables were those by selected Cox regression. The role of 
hyperparameters in here is to examine how these variables have been handled in the 
network. 
5.4.1 Group ARD Concept 
Owning to the structure of categorical data, each of the input variables was transformed 
into several binary input attributes in the network. Originally, the ARD technique 
assigns a single value of the hyperparameter alpha to each input variable. In this new 
approach, instead of assigning a value of alpha to the group of weights which fan out 
from each input node, a single value of alpha is associated with the weights that fan out 
from all of the input attributes which correspond to a single variable. This is called the 
grouped ARD technique. 
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This approach was applied to the low-risk cohort and implemented with a 5-fold cross 
validation again and same input variables were used. Different numbers of hidden nodes 
were tested, the best network output estimation was given by 18 hidden nodes. The 
results are summarised in figure (5.10) - (5.11). 
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Figure (5.10): Prognostic indexes that evaluated by the grouped ARD Bayesian 
approach for the low-risk cohort and five prognostic groups were partitioned by 
visualisation grouping method. 
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Figure (5.11): The grouped ARD network predicted mean survivorship for prognostic 
groups and the corresponding Kaplan-Meier estimate of the survivor functions. The 
separation of prognostic groups over 5 prognostic groups is better than the single alpha 
ARD approach and also better survival estimation for each of the prognostic groups. 
The results show that the grouped ARD technique is successful and the accuracy of the 
estimated survival for prognostic groups have also been improved. However, the value 
of alpha hyper-parameters for each input variable are strangely large, further 
investigation will be reported in section (5.4.2). Hence, the neural network analysis will 
be based on the use of grouped ARD technique and also the prognostic groups 
partitioning method. We will be using the log-rank test to choose the optimal position of 
the thresholds to aggregate prognostic groups from the ranked prognostic index values. 
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5.4.2 Baseline attributes determination 
The value of alpha hyper-parameter in the single alpha approach was around 6. 
However, the alpha values of the grouped ARD approach varied between 22.57 to 
84.71. The two sets of alpha were very different. The value of alpha corresponds to an 
inverse variance, as the bigger the posterior variance of weights, the smaller value of 
alpha would be, which leads to higher significant influence of the corresponding input 
variable to the output estimation. 
The large value of grouped ARD suggests some redundancy between the group of 
attributes corresponding to a single input variable. After all, the attributes for each 
variable must sum to one, imposing a constraint on their values. 
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5.4.2.1 Applying the conventional ARD technique 
The network setting has not been changed, still trained with 18 hidden nodes, each of 
input variable was received a separate hyper-parameter alpha. Table (5.1) displays the 
values of alpha of each attribute. 
Histology 1 2 3 
Alpha value 11.94 1513.8 70.216 
Pathological size 1 2 
Alpha value 14.789 461.5 
Node stage 0 1 
Alpha value 14.726 369.03 
Nodes ratio <=20% 20-30% 30-60% 60%+ Unknown 
Alpha value 11.149 2082.2 2030 12.759 8447.2 
Table (5.1): The reading of alphas that are corresponding to each of the input nodes. 
One of the alpha values within a variable is distinguishably large. 
It is clear that for each variable one attribute may be regarded as irrelevant. In order to 
maintain the consistency, the attribute becomes the baseline is same as the Cox 
regression, the lowest hazard attribute of the variable, the value of the baseline for that 
variable is coded by all remaining attributes equal to zero. 
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5.4.2.2 Adding the baseline attribute assumption to the training criteria 
By considering the baseline attribute approach, the network was retrained with the 
grouped ARD technique and included the baseline attributes assumption. The chosen 
baseline attribute for each variable was same as the baseline category for Cox 
regression. The results show that the alpha value of each variable has been significantly 
reduced. The new reading of alphas are 1.4353,1.1534,1.6545,3.0963 and 2.6333 for 
variables histology, pathological size, node stage, nodes ratio and time respectively. 
The prognostic indexes are still within the range of -4.5 to -1 as displayed in figure 
(5.12) and the distribution of samples are similar to our previous results, the 917 
samples have been successfully partitioned into 4 prognostic groups by the log-rank 
test, as illustrated in figure (5.13). Their predicted mean survivorship at year 5 is varied 
between 0.97 to 0.22 and each respectively contains 75,341,460 and 41 number of 
subjects. The network survival predictions in general can be concluded as acceptable. 
Although the network estimation for group I and group 4 show a small deviation from 
the corresponding Kaplan-Meier estimate of the survivor functions, the curves are still 
being included within the confidence interval bands, considering that their confidence 
interval bands are bigger than the other two groups. 
The results show there is a need to define baseline population when handling 
categorical data. The baseline attributes are given values of zeros and the same attribute 
in each variable is allocated to both of the neural networks and the Cox regression. 
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Figure (5.12): The neural networks computed prognostic indexes using the grouped 
ARD technique and baseline attributes assumption. Four prognostic groups were 
divided by the log-rank test. 
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Figure (5.13): The network predicted mean survivorship for prognostic groups after 
applying the grouped ARD technique and the baseline attributes assumption and the 
corresponding Kaplan-Meier estimate of the survivor functions. The curves are well 
separated and the network prediction is acceptable. 
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5.4.2.3 Displaying the attribute profiles of each prognostic group 
Since the techniques of data analysis using neural networks has been refined, it is 
necessarily to determine the characteristic of each prognostic group, in which the 
variables that play a leading role of in each prognostic group are examined. Therefore, 
the variable attribute histogram for each prognostic group is displayed in figure (5.14). 
Clearly, particular attributes of variables are dominated in particular prognostic group. 
Group I is the highest survival group of the data, the attribute of histology moves from 
attributes 2 and 3 to mainly attribute 1 from group 1 to 2. Over the 4 prognostic groups, 
the pathological size and node stage move gradually from attribute I to 2 and attribute 0 
to 1, respectively. Finally, all the variables are concentrated on their particular attribute 
that creates prognostic group 4, which is the lowest survival group. 
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Figure (5.14): The attribute profiles of prognostic groups which generated by the neural 
networks with the application of grouped ARD technique and the baseline attribute 
assumption in which the behaviour of each variable over prognostic groups can be 
monitored. 
Chapter 5: Neural Network Breast Cancer Application 
5.5 Bias correction of network output due to heavily skewed binary data 
The Bayesian framework does not take account of the skewed distribution of target 
labels in binary classification problems, with the consequence that all network outputs 
are marginalised to the mid-range of the value. In the evidence approximation to the 
integral of 
P(c, I x, D) =J g(a)P(a I x, D)da, then 
%iS2 
P(c, I x, D) g (1 +8 )-1/2 aMP 
ý 
where s2 is the variance of the sample distribution, a -- N(aMPIs 2) . The P(c, I x, D) 
is the probability of class membership c, given the data x and training data set D. 
For a two classes problem, the network output is adjusted to minimise the probability of 
misclassification of the given input data with the decision boundary, corresponding to a 
network output of p(C, I x, D) = 0.5 . The form of the logistic sigmoid activation 
function determines that aMP (x, WMP) =0. The p(C, I x, D) = 0.5 statement is no 
longer held when the data are heavily skewed. Some modifications to the network error 
and estimates have been proposed, Lisboa et al (2000). Firstly, by weighting the cost 
function using Bayes' theorem so the network is as if trained with an equal prior. In 
applying Bayesian neural networks to the modelling of censored data, it is necessary to 
re-weight the error function to equalise the heavily skewed distribution of mortality 
indicator indexes follows 
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LL = -ý 1og(Y ) 
r" 
+ log(1- yn ). 
1- tn 
n 2d 
12(1-d) 
ý 
where d represents the frequency of death, t, is the target labels and yn is the network 
outputs. This modification also applies to the gradient and the Hessian calculations in 
the similar manner. 
The conditional network estimates are then compensated using Bayes' theorem, to take 
account of the true prior distribution for the target labels, resulting in conditional 
network estimates that marginalise to the priors, d, which is the averaged hazard in this 
study, i. e. 
T,, (x)d 
y f; 
(x) 
yk (x)d + (1- yR (x))(1- d) ' 
where Yg (x) is the network output. 
When yg (x) = 0.5, it follows that 
_ 
0.5d 
=d. (x) 0.5d + (1- 0.5)(1- d) 
So, yx (x) marginalises to 0.5 while yg (x) marginalises to d. 
The calculation of the averaged hazard involved two parts, (i): the probability of death 
at each time interval is the total number of death within the time interval divided by the 
total number of patients at risk at the beginning of the time interval, (ii): then averaging 
the probabilities of death by the number of time intervals. 
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5.5.1 Demonstration of the effect of network output marginalising towards class prior 
The breast cancer analysis was repeated using the PLANN model, but refined into 
monthly bases. The network estimates were marginalised towards the averaged hazards 
of the data, which was calculated by averaging the hazard of each time interval. The 
network was still using 18 hidden nodes, the grouped ARD technique and baseline 
attributes assumption were also applied, mortality risk groups were partitioned by the 
log-rank test, finally, the analysis was implemented using the 5-fold cross validation. 
The calculation of cumulative survivorship involves a series of network output 
multiplication, described in section 5.2.2.1. Therefore, any bias in the calculation of 
each hazard rate causes a huge bias after multiplication over several time intervals. 
Figure (5.15) - (5.16) demonstrate the effect of marginalisation towards midpoints and 
the class priors. Figure (5.15) displays four different network outputs, the original 
output, the network output marginalised towards midpoint; the network output 
marginalised towards averaged hazard from the original output; and marginalised 
towards averaged hazard from the network output had marginalised towards midpoint. 
Nevertheless, the top 4 curves in figure (5.16a) are the network survival prediction for 4 
prognostic groups which marginalised towards averaged hazard and the lower 4 curves, 
the corresponding network prediction marginalised towards midpoint. Figure (5.16b) is 
the corresponding Kaplan-Meier estimate of the survivor functions. The network 
outputs are seriously damaged when the bias correction is not applied. 
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Figure (5.15) (a): The original output predicted by the neural network (-) and the 
marginalised output (*), averaged from all patients in low-risk cohort. (b): the original 
network output marginalised towards averaged hazard directly (-) and the midpoint 
marginalised result marginalised towards averaged hazard (*). 
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Figure (5.16), (a): The top 4 curves are the network survival prediction which 
marginalised towards averaged hazard and the lower 4 curves are the survival prediction 
which marginalised towards midrange and (b) is the corresponding Kaplan-Meier 
estimate of the survivor functions. 
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5.5.2 Complete the low-risk Cohort analysis into monthly study 
After defining the necessary techniques to correct the marginalisation to take account of 
the skewness of the target distribution, still using 18 hidden nodes, the network was 
retrained, same input variables as before and with grouped ARD. The time intervals 
have been refined into a monthly study over 60 months. Thus, data were replicated 
more frequently than the yearly study and the mean hazard per time interval was 
correspondingly smaller. For the individuals who survived more than 60 months were 
censored at month 61. 
Figure (5.17) demonstrates when the log-odds ratio, ä (x, WMP) , is zero, the 
marginalisation of yg (x) is toward 0.5 as if the case of network trained with equal 
priors. After compensation for the time value of the prior, yg, (x) marginalises to the 
averaged hazard in this case 0.0032. The new range of prognostic indexes lies between 
-3 and 5. Four prognostic groups are partitioned by the log-rank test and the patients 
allocation is 56,359,460 and 42 respectively, with a majority of patients still allocated 
to group 3, as illustrated in figure (5.18). 
Only the network predicted mean survivorship for the lowest survival group is not 
accurate showing 0.16 error when comparing figure (5.19a) and (5.19b). However, all 
survival curves are included within the Kaplan-Meier estimated confidence interval 
bands. Since the network outputs were marginalised toward the mean hazards, thence, 
the mean survival rate at year 5 is around 0.7, therefore the error generated by 
prognostic group 4 can then be explained. One solution to solve this situation is to 
model each prognostic group separately, which would allow accurate prediction of 
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survival for the patients in each group, given the prognostic group allocation already 
decided on the basis of the most likely values of a, namely aMp . 
There is a significant difference observed from the attribute profiles over prognostic 
groups in figure (5.20), when comparing with the Cox regression approach in figure 
(4.14). The profile of variables in each prognostic group is more highly concentrated on 
a particular attribute, thus reducing the overlap between prognostic groups. 
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Figure (5.17): The network outputs and their associated prognostic index in four format, 
namely original network output (Output), network output marginalised towards 
midpoint (Output & Marginal), network output marginalised towards average hazard 
using the outputs marginalised towards midpoint (Output & Marginal & Corr) and 
network output marginalised towards average hazard directly (Output & Corr). 
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Figure (5.18): The log-rank test partitioned 4 prognostic groups or the low-risk cohort, 
the network outputs are marginalised towards the averaged hazard of the data. 
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Figure (5.19): The network estimates mean survivorship for prognostic together with 
the corresponding Kaplan-Meier estimate of the survivor functions. The network is 
trained with bias correction technique and the outputs are marginalised towards 
averaged hazard. The survival prediction for prognostic groups is concluded as 
accurate, except group 4. 
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Figure (5.20): The attribute profiles for prognostic groups, which the network outputs 
are marginalised towards averaged hazard. The distribution of patients has been 
changed significantly from the previous neural network result, they are more 
concentrated on particular attribute in each variable. 
When the analysis has been refined to a monthly study, more detailed information can 
be extracted from the data, including a smooth prediction of the hazard, shown in figure 
(5.21). The results so far indicate that a small group of 42 patients in this cohort has a 
relatively low survival. This group of patients will be examined further and the results 
are summarised in section (6.4). 
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5.6 Assumption of proportional hazard 
The proportional hazards model allows a non-constant hazard rate to be modelled 
without making any assumption about the underlying distribution of the hazards in the 
different groups, but is requires the hazards in the groups remain proportional over time. 
Therefore, the time dependence of the hazard is that observed for the baseline 
population. This assumption was assessed by the commonly used Cox-Snell residual 
plot or some other residual plots, all methods have confirmed no significant evidence 
that the data were not fitted into the proportional hazard assumption, as reported in 
section (4.1.2). However, such residual plots are not precise in verifying hazard 
proportionality between prognostic groups. 
Handling censorship is a main feature of the PLANN model; nevertheless it is also 
capable of generating a smooth hazard rate over time. Figure (5.21) displays the mean 
hazard for each of the 4 prognostic groups over time and shows that the hazard of each 
prognostic group was not uniformly proportional to each other. The peak hazard for 
each group is retarded slightly as the hazard increases, indicating only a minor deviation 
from the proportionality assumption over the time frame of the study. Gore et al (1984) 
confirmed that if time to peak hazard is earlier in some prognostic groups than in others, 
then the proportional hazard assumption is no longer sustained and has been the case in 
breast cancer. 
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Neural network model testing the proportional hazard assumption 
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Figure (5.21): The network predicted hazard probability of the 4 prognostic groups over 
60 months for the low-risk cohort. The arrow point at each curve is where the 
corresponding peak hazard occurred. 
5.7 Discussion of chapter (5) 
In this chapter, it was demonstrated the PLANN model is capable of handling censored 
survival data and can be adopted easily by a standard neural network model for 
classification problem. The Bayesian neural network has performed as well as the Cox 
regression, although they responded differently and produced slightly different 
allocations into the prognostic groups, the neural network being more specific in 
attribute profiles in each risk group. Moreover, the robustness of the Cox regression has 
also been demonstrated when the non-proportionality of hazard has been confirmed 
within the data. 
The same data analysis will be repeated for the high-risk cohort which is summarised in 
chapter (6). Variable interactions are also investigated using the neural network model 
regularised with ARD for high-risk cohort. 
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6 High-risk cohort 
The high-risk cohort contains all the remaining subjects who did not fit into clinical 
separation criteria for the low-risk cohort. This includes any occurrence of large 
tumours, fixed affected nodes in the axilla, and distant metastases. However, it also 
includes the subjects with pathological size coded unknown, making a total of 633 
subjects. The following sections contain the neural network analysis using different 
models, Cox selected variables and ARD selected variables. All of the analyses for the 
high-risk cohort are implemented with a 3-fold cross validation, in order to reduce the 
computational time, rather than a 5-fold cross validation as for the low-risk cohort, 
which still leaves significant amount of samples for network training. 
An analysis of the high-risk patient group identified from the low-risk cohort by the 
neural network in previous chapters, was also included, with the aim of determining the 
characteristics of survivorship in this group. Additionally, variable interactions are 
investigated in this chapter, by identifying variables with ARD then including explicit 
interactions into Cox regression. 
6.1 Neural networks analysis using the Cox selected variables 
Forward-stepwise elimination was again employed to select the optimal Cox model for 
the high-risk cohort from the original 18 variables, the details are summarised in table 
(4.4). The selected variables and the time variable formed the network input layer, 
altogether 16 input nodes when the baseline attribute is removed. The baseline 
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population was chosen as in the Cox regression, to be the lowest hazard categories. A 
single hidden layer of 18 hidden nodes was used for consistency with previous results. 
The single output node represented the hazard rate of an individual at a particular time 
interval. Grouped ARD was also used. 
The analysis consisted of a monthly study over 5 years, marginalising the hazards 
towards the average hazard of the training data. The log rank test was, again, employed 
to define prognostic groups. After completing the network training process, the final 
values of the hyper-parameter alpha were ranked and used to identify the main 
contributing variables, which are menopausal status, node stage, pathological size, 
clinical stage and nodes ratio. 
A total of 3 prognostic groups were identified, containing 248,174 and 211 patients, 
respectively. The thresholds determined by the log-rank test are indicated in the plot of 
the prognostic indexes, figure (6.1). The network predicted mean survivorship for 
prognostic groups and the corresponding Kaplan-Meier estimate of the survivor 
functions are shown in figure (6.2). Good survival prediction for all groups is obtained, 
as with the low-risk cohort. There is a minor inaccuracy in the estimates of survival for 
prognostic group 2, which is the consequence of the network output marginalisation 
towards the mean hazard for all of the groups. The overall mean hazard has been 
suppressed towards 0 due to the patients in the lower risk group, prognostic group 1. 
The highest survival group is highly populated with node stage 0, representing negative 
node, and pathological size coded as unknown. The remaining variables used for the 
clinical data separation criteria indicate they may belong to the low-risk cohort. 
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Finally figure (6.3) shows the attribute histograms for each of the prognostic groups. In 
each prognostic group, one or two variables are most prominent, thence each of the 
variables contributes differently to each group. However, the menopausal status and 
pathological size do not show clearly differentiated attribute profiles over the three 
prognostic groups. Moreover, apparently, the menopausal status was given the largest 
value of alpha, and its profile is similar across all of the prognostic groups. This 
indicates that menopausal status contributes to the survivorship estimation through 
interactions with the other variables. 
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Figure (6.1): Prognostic index plot of high-risk cohort and the log rank test partitioned 
prognostic groups. 
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Figure (6.2): (a) Neural networks predicted survivor function for prognostic groups 
using the 5 independent Cox regression selected variables and (b): The corresponding 
Kaplan-Meier estimate of the survivor functions. 
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Figure (6.3): The high-risk cohort attribute profiles of network trained with Cox 
regression selected variables for prognostic groups. 
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6.2 Neural networks model selection using ARD technique 
When the regularisation coefficient assigned to a particular input grows large, the 
attached network weights are damped down towards zero. This is how the technique of 
Automatic Relevant Determination (ARD) controls the irrelevant input variables from 
damaging the network output performance. 
The process of model selection begins with including all of the independent variables in 
the model, resulting in a set of values for the hyper-parameter a. In this case, a group of 
attributes corresponding to same variable shares same value of alpha. The network 
output marginalisation to the mean hazard ratio and baseline attributes were also used. 
The variable removal criterion consists ranking the alpha values by size, then gradually 
removing the input variables with significantly large alpha values from the model, until 
no more variables could be removed without substantial detriment to model 
performance. This amounts to backward stepwise elimination. 
The model selection for the high-risk cohort using the ARD started with all the 14 
variables, excluding the four surgical variables, as described in section (4.4.1). 
Although the time covarates are given a large value of alpha, they are not considered as 
candidate for variable selection and kept in the model. Removing time from the input 
variables would result in a survival model with time independent hazard. Therefore 
survival would be exponential to time. diameter, pathological size, clinical stage and 
number of nodes involved were the first set of variables to be removed from the model. 
Finally, 6 variables were left, namely, menopausal status, predominant site, tumour 
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stage, node stage, histology and nodes ratio. The details were summarised in table (6.1). 
The ARD selected variables are slightly different from those selected by Cox regression 
for this cohort, the common variables of two models being menopausal status, node 
stage and nodes ratio. Even though the rest of variables from two models are different, 
some of the variables represent similar kinds of information such as tumour stage and 
pathologic size. Only the predominant site and histology are selected differently in the 
ARD model. These newly selected variables will be tested for their predictive power in 
section (6.2.1). 
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Variables Value of Alpha 
(iststage) (2° stage) (3r stage) Final Model 
Menopausal Status 7.0357 2.9952 3.1 6.443 
Age Group 4.3999 3.9710 8.3102 
Predominant Site 7.6109 4.6426 3.4912 6.6387 
Side 5.3807 11.7232 
Diameter 20.9377 
Tumour Stage 5.2955 2.4935 1.9996 5.1673 
Node Stage 8.7874 2.6625 4.155 4.4299 
Metastasis Stage 5.29336 10.54498 
Pathological Size 12.8370 
Manchester Stage 12.3407 
Histology 5.4018 2.5584 3.5155 6.3668 
Nodes Involved 10.7831 
nodes ratio 5.1505 2.6657 3.3531 4.4423 
Table (6.1): The value of alpha of variables involved in the different stages of' ARI) 
model selection process. 
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6.2.1 Network trained with the ARD selected model 
The network was re-trained with the ARD selected variables, still with 18 hidden nodes, 
and with bias correction terms to marginalise the network output towards the average 
data hazard. The results are displayed in figure (6.4) to (6.6). Three distinct mortality 
risk groups are identified containing 244 171 and 218 patients, and the observed 
survivorship at month 60 are 0.72,0.4 and 0.21 respectively. Although each of the 
network predicted mean survivorship falls into the confidence interval bands estimated 
by Kaplan-Meier, the survival estimation of prognostic group 2 is not as accurate as for 
the other groups, owing to the effect of marginalisation towards the overall averaged 
hazard. This can be solved by modelling each prognostic group separately. Also, the 
survival curves are not as well separated as with the neural network using Cox selected 
variables. However, the model is still useful to identify candidate variables that may act 
through interactions with other variables. 
These are the variables that have similar attribute profiles for different prognostic 
groups, namely, menopausal status, predominant site and histology. A further analysis 
base on these variables for variable interactions is summarised in section (6.3). 
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Figure (6.4): The 3 partitioned prognostic groups using the ARD selected variables for 
the high-risk cohort. 
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Figure (6.5): The neural network predicted survivor function using the 6 ARt) selected 
variables for the prognostic groups and the corresponding Kaplan-Meier estimate of the 
survivor functions. 
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Figure (6.6): The attribute profiles of network trained with ARD selected variables for 
prognostic groups. 
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6.3 Assessing pairwise interactions for the high-risk cohort 
Although the network trained with the ARD selected variables did not produce better 
results than the network trained with the Cox selected variables, the variables selected 
differ and this may indicate the presence of variable interactions, which influence the 
constitution of prognostic groups, and the prediction of survival for individuals. 
It is very difficult to determine explicitly the functional form of the implicit interaction 
between variables in the neural network model. Cox regression allows interaction terms 
to be included explicitly in the model, and hence tested for their statistical significance. 
The 6 ARD selected variables were divided into 2 categories, specific and non-specific 
variables. Non-specific variables have similar attribute profiles for different prognostic 
groups in figure (6.6), which specific variables show a gradual transition in the 
univariate profiles across the prognostic groups. The variables classified as non-specific 
variables are predominant site, menopausal status and histology. The process of 
identifying interactions term for the high-risk cohort using Cox regression was divided 
into three stages. Firstly, the 3 pairwise interactions between the non-specific variables 
were used alone to model the data; then the 3 pairs of specific variables were used as 
interaction terms; finally, the 9 cross-terms from the two sets of variables were used to 
model the data. The results from these studies are listed in table (6.2). 
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Significant interaction Significant interaction Significant interaction 
terms between non- terms between specific terms between non- 
specific variables variables specific and specific 
variables 
Histology * Predominant Nodes ratio * Node stage Menopausal status 
site tumour stage 
Hsitology* Menopausal Nodes ratio * Tumour Menopausal status 
status nodes ratio stage 
Histology * Tumour stage 
Histology * node stage 
Table (6.2): The significant interaction terms of ARD selected variables for high-ris 
cohort. 
Following this preliminary pre-filtering of candidate interaction pairs, the 8 pairs of 
variable interaction terms were put together with the 14 independent variables and the 
optimal Cox model was identified by forward stepwise model selection. This resulted in 
a final model comprising an independent variable, clinical stage, together with the 
pairwise interaction between nodes ratio * tumour stage. 
The results of Cox regression fitted with this optimal model with a 3-fold cross 
validation are summarised in figures (6.7) to (6.9). The Cox prognostic indexes, 
including a contribution from the interaction term, and the Cox predicted and Kaplan- 
Meier estimates of the mean survival function for each the 3 partitioned mortality risk 
groups, are shown together with the variable attribute histograms for each of prognostic 
group. Furthermore, figure (6.10) displays the values of tumour stage for each value of 
nodes ratio in each of the 3 prognostic groups, to show the interaction between these 
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two variables. There is an improved separation between the expected survival of 
prognostic groups, and the patients allocated to each group are, 214,278 and 139, 
respectively. Moreover, the survivor probability at 60 months for the highest risk group 
has gone down below 0.1. Also all of the variables show clearly different attribute 
profiles over prognostic groups, as shown in figure (6.9). The results have confirmed 
that a variable interaction is present in the data and the interaction term twnnour stage 
nodes ratio contributes to the identification of high-risk prognostic group. 
The ARD technique is a useful tool for seeking variable interactions in the data and 
combining with the Cox selected independent variables, yields a powerful predictive 
model. The predictive power of the ARD selected model for high risk patients can also 
be tested once more by introducing the network identified special high-risk patients 
group from the low-risk cohort to the high-risk cohort. The analysis is reported in the 
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Figure (6.7): Cox regression defined prognostic groups involving a pairwise interaction 
between variables tumour stage and nodes ratio for the high-risk cohort. 
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KM estimated cum sunmal for HRG. involving t'node ratio 
(b) 
Figure (6.8) (a): The Cox regression predicted survival function involving the 
interaction term tumour stage * nodes ratio for prognostic groups from high-risk cohort 
and (b) the corresponding Kaplan-Meier estimates survival function. The prognostic 
groups are well separated and the survivorship of prognostic group 3 has driven toward 
below 0.1. 
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Figure (6.9): The variable profiles of Cox regression involving variable interaction term 
turmour stage and nodes ratio for high-risk cohort. Each of the variables has shown a 
clear attribute profile over the prognostic groups. 
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Patients distribution for the prognostic groups of high-risk cohort 
involving interaction nodes ratio * tumour stage 
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tumour stage and nodes ratio, where nodes ratio 5 represents the missing data attribute. 
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6.4 Inclusion of the highest risk group from the low-risk cohort into the high-risk 
cohort 
The predictive models fitted to the high-risk cohort were also applied to the high 
mortality group from the low-risk cohort. Both the ARD selected variables, and the Cox 
selected variables were used with neural network, in order to compare the predictive 
power of each set of variables for these patients. The analysis does not involved 
retraining of the network, simply re-uses the weights calculated by the network trained 
previously with the ARD and Cox selected variables with 3-fold cross validation. The 
estimated hazards for this high mortality group of each model were gathered and 
averaged over 3 set of results. Then the mean estimated survivorship over 60 months 
was projected each onto the graph along with the other prognostic groups generated by 
the ARD and Cox selected model for the high-risk cohort. 
Figures (6.11) - (6.12) display network predicted survivor function for the high 
mortality group together with the original prognostic groups and the corresponding 
Kaplan-Meier estimates of survival using Cox and ARD selected variables respectively. 
The figures show that the Cox selected variables do not accurately predict the 
survivorship of these 42 patients. In contrast, the ARD selected variables show an 
accurate prediction and similar prediction to the PLANN model developed for the low- 
risk cohort. The survival curve of these patients crosses over the survivorship of the 3 
prognostic groups in the high-risk cohort that ARD generated. During the first 7 months 
following surgery, this group of patients displays a similar survivorship as group I, then 
the survival gradually decreases from month 8 to month 42 where it crosses over group 
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2, and finally joins with group 3 from month 42 onward, reducing survival probability 
to 0.26 at month 60. 
When examining the three sets of models carefully, the Cox selected for the low-risk 
cohort, the Cox and ARD selected for the high-risk cohort, only the histology existed in 
both of the ARD selected model and the Cox model for the low-risk cohort, but was 
absent in the Cox selected model for the high-risk cohort. The histology could be one of 
potential variables that describe the survivorship of the high mortality group, or indeed, 
a variable interaction could be the alternative possibility. Further investigation is 
summarised in section (6.5.1). 
Included P's ep group to MRG. Bayesian network using Cox variables Kapl-Marar aal-. lad aunmal, mcludW IM ap group lu MHV 
-- -JU ýU ! 41 LII 
Tune ýn Mnnlh" 
(a) (h) 
Figure (6.11): (a) The neural networks predicted survivor function for the high-risk 
cohort prognostic groups and the specific group using Cox selected variables and (h): 
the corresponding Kaplan-Meier estimate of the survivor functions. 
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Figure (6.12): (a) The neural networks predicted survivor function for the high-risk 
cohort prognostic groups and the special group using ARD selected variables and (b): 
the corresponding Kaplan-Meier estimate of the survivor functions. 
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6.5 The key variable to model the high mortality group in the low-risk cohort 
Previous results suggested that histology is the factor that best separates this special 
high mortality group from the rest of the low-risk cohort. The following contents in this 
section are the test of this statement and to consider possible variable interaction terms 
within the low-risk cohort. 
6.5.1 Detecting the variables that histology interacted with 
The 3 possible pairwise interaction terms from the Cox selected variables for the low- 
risk cohort, histology* node stage, histology * pathological size and histology * nodes 
ratio were included to the Cox regression model selection procedure alone to model the 
data, and resulting that they were all significantly responded to the survivorship of the 
data. These three pairs of variables were then entered into the model selection process 
again, together with the 14 independent variables. The final model contains 
pathological size, histology, nodes ratio and histology * node stage. Figure (6.13) 
displays the Cox partitioned prognostic groups using this model. The Cox predicted 
survivorship for the mortality risk groups are displayed in figure (6.14) together with 
the corresponding Kaplan-Meier estimate of the survivor functions. The attribute 
histograms of prognostic groups are displayed in figure (6.15) and figure (6.16) shows 
the attribute histograms within the interaction term. 
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Prognostic indexes of Cox regression calculated involving histý n 
Figure (6.13): Cox regression partitioned mortality risk groups for the low-risk cohort 
involving the interacted variables histology * node stage and contained 61,207,579 and 
68 patients respectively. 
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Figure (6.14): (a) Cox regression predicted survivor function for the 4 prognostic 
groups of low-risk cohort involving the interacted variables histology * node stage and 
(b) the corresponding Kaplan-Meier estimate of the survivor functions. 
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Figure (6.15): Attribute histograms of the model involving histology " tiode stage 
interaction term over prognostic groups for the low-risk cohort. The prognostic group I 
contained fewer patients and the profile is similar to the result of neural networks using 
Cox selected variables for the low-risk cohort. 
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Patients distribution for the prognostic groups of low-risk 
cohort involving interaction histology * node stage 
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Figure (6.16): Distribution of patients over the interaction term histology and node 
stage. 
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The results show that histology * node stage actually is not the main factor that 
describes the survivorship of the high mortality group as expected, even though 
histology is one of the predictive variables being selected. However, histology * node 
stage contributes to the highest survival group when comparing the expected 
survivorship of prognostic groups with the result without involving the interaction term. 
The expected survivorship involving, histology * node stage of prognostic group I has 
been improved better, closer to 1, and also the corresponding attributes profiling even 
more specific and contained less patients, as illustrated in figure (6.17)-(6.18). 
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Figure (6.17): (a) The Cox predicted survivor function for the prognostic groups 
involving histology * node stage and (b) without involving interaction term. 
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Figure (6.18): (a) Attribute histograms of prognostic group 1 involving interaction term 
histology * node stage and (b) without involving interaction term. 
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6.5.2 Determine the interaction term that describes the survivorship of the high 
mortality group in the low-risk cohort 
Since the histology is not the factor that describes the survivorship of the high mortality 
group, the remaining possible interaction terms from the ARD selected model for the 
high-risk cohort are nodes ratio * node stage, nodes ratio * pathological size and 
pathological size *node stage. The results show that nodes ratio * node stage and 
pathological size * node stage were both significant to the survivorship of the data. The 
final model selected with forward stepwise elimination contained three independent 
variables, namely, node stage, pathological size and histology, and an interaction term 
nodes ratio * node stage. 
This model is fitted to the Cox regression with 5-fold cross validation again. Figure 
(6.19) displays the Cox partitioned prognostic groups involving interaction term nodes 
ratio * node stage. The Cox regression predicted survivor function for the mortality risk 
groups with the corresponding Kaplan-Meier estimate of the survivor functions are 
displayed in figure (6.20). The attribute profiles for prognostic groups are shown in 
figure (6.21). 
The results indicate that the interaction term nodes ratio * node stage is the factor that 
best differentiates the survivorship of the high mortality group. The attribute profiles are 
more specific over the prognostic groups. However, the attribute histograms for the 
prognostic group 1 is not as specific as the model involving histology * node stage. 
Including the two interaction terms together in a model may retain good differentiation 
for the highest survival group, which histology * node stage contributed to, and the 
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lowest survival group, where the interaction between nodes ratio * node stage is 
significant. 
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Figure (6.19): The Cox regression partitioned mortality risk groups for the low-risk 
cohort using the model involved interaction term nodes ratio * node stage and 
contained 116,331,427 and 43 patients respectively. 
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Figure (6.20): (a) Cox regression predicted survivor function for the 4 prognostic 
groups in low-risk cohort involving the interaction term nodes ratio * node stage and 
(b) the corresponding Kaplan-Meier estimate of the survivor function. 
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Figure (6.21): Attribute histograms of the prognostic groups involving nodes ratio 
node stage interaction for the low-risk cohort. 
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Figure (6.22): Distribution of patients over interaction term nodes ratio and node stage, 
where nodes ratio 5 is represents the missing data attribute. 
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6.5.3 Modelling both interaction terms together for the low-risk cohort 
A new model was selected for the low-risk cohort, which contained the interaction 
histology * node stage and nodes ratio * node stage, in addition to histology and 
pathological size. Forward stepwise elimination was employed once again. The Cox 
regression results are presented in figure (6.23) to (6.25) in the same sequence as the 
previous study but not including the cross distribution of the interacting variables. 
The results with Cox regression including 2 interactions terms are poorer than with the 
neural network using the same base variables. In other words, the ARD model with 
histology, pathological size, node stage and nodes ratio has a better separation between 
the prognostic groups. In the Cox model with two interaction terms, the prognostic 
group I and 4 contained more patients and were less specific. It appears that in the 
linear Cox regression model, the two interaction terms are working against each other. 
Although the factors that describe the survivorship of the highest survival and lowest 
survival groups have been identified individually, their power cannot be merged and 
expanded using Cox regression. It demonstrated the strength of neural networks in 
applying the interactions selectively to different prognostic groups. 
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Figure (6.23): Cox regression partitioned mortality risk groups involving the two 
interaction terms nodes ratio * node stage and histology * node stage, contained 134, 
313,399 and 71 patients respectively. 
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Figure (6.24): (a) Cox regression predicted survivor function for the prognostic groups 
involving the interaction terms nodes ratio * node stage and histology * node vloi, 'e and 
(b) the corresponding Kaplan-Meier estimate of the survivor functions. The outcome 
does not meet the expectation. Neither the specified low survival nor the high survival 
group was displayed. 
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Figure (6.25): The attribute histograms for the prognostic groups which involving 
interaction terms nodes ratio * node stage and histology * node wage for the low-risk 
cohort. 
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6.6 Conclusion 
In this chapter, the power of neural network ARD model selection towards seeking and 
handling variable interactions has been demonstrated. It was also combined with Cox 
regression, to find an optimal model for each of the cohort that separates well the 
prognostic groups and has specific attribute profiles. 
In the high-risk cohort, the final model only contained one independent variable, 
clinical stage, together with the ARD identified interaction term tumour stage* nodes 
ratio. Note that clinical stage is a composite variable, combining tumour, node and 
metastasis stages. The survival predictions generated by this model are the best among 
all models for the high-risk cohort. 
The situation in the low-risk cohort is not straightforward. Although the interaction 
terms contributing to the highest and lowest mortality groups have been identified 
separately, the results show that they cannot be put together into a single Cox model. 
The best result is given by the neural network model trained with Cox selected variables 
for the low-risk cohort. 
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7 Effectiveness of predicting missing data using logistic regression 
In section (3.2.2), nominal logistic regression was proposed to predict missing data 
from a set of complete variables, using feed forward variable selection. 
Within this chapter, the effectiveness of the predicted values is evaluated. The process 
starts by modelling each of the cohorts using Cox regression. Variable interactions are 
not considered at this stage. The substantial improvement is sought for accuracy of 
survivorship prediction, differentiation between the survival of prognostic groups, and 
characteristic attribute profiles. Finally, the Cox regression analysis was benchmarked 
with the Bayesian PLANN model using the high-risk cohort, where interactions 
between predictor variables have caused difficulties for Cox regression. 
7.1 Cox regression analysis of filled-in missing data using previously selected 
models 
7.1.1 Cox regression analysis of the low-risk cohort with missing data filled-in using 
nominal logistic regression 
The 4 variables listed in section (3.2.2) were the variables that contained large amount 
of missing values. Some of the other variables also contain missing data, but only a 
small fraction, these cases (77 cases) were discarded, in order to be used to predict the 4 
variables contained missing values, leaving 1473 completed cases. 
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Since pathological size is a clinical criterion for patient cohort allocation, predicting it 
changes the composition of the low and high-risk cohorts, as follows 
Before filling-in missing 
data 
After filling-in missing 
data 
Low-risk cohort 917 1070 
High-risk cohort 633 403 
Table (7.1): Patients allocation of each cohort before and after filling-in missing data. 
The model used for the initial analysis was the Cox selected model for the original low- 
risk cohort, using 5-fold cross validation. Figure (7.1) displays the ranked prognostic 
indexes and the 3 mortality risk groups that the log-rank test partitioned, containing 
contained 215,645 and 210 patients respectively. The distribution of the prognostic 
indexes has shifted to lower values when compared with the original results in figure 
(4.9). Figure (7.2) shows the Cox predicted mean survivorship for each prognostic 
group with the corresponding Kaplan-Meier estimate of the survival functions. The 
survivorship of the highest and lowest survival group at 5 years is 0.9 and 0.52. 
The attribute histograms for the prognostic groups are displayed in figure (7.3). The 
survival prediction for the prognostic groups is a slightly better match of the Kaplan- 
Meier curves than the previous Cox results where the missing data were treated as 
separate categories. The confidence intervals calculated by Kaplan-Meier estimation for 
each prognostic group are smaller and the attribute histograms also show better 
profiling, except for histology, where the profile is less specific than previously. 
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Figure (7.1): Cox calculated prognostic indexes for the filled-in low-risk cohort and log- 
rank test partitioned prognostic groups. 
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Figure (7.2): (a) The Cox the Cox predicted mean survivorship for prognostic groups 
with (b) the corresponding Kaplan-Meier estimate of the survival functions. 
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Figure (7.3): The attribute histograms of prognostic groups for the filled-in low-risk 
cohort. 
The original 4 prognostic groups were merged into 3 groups. Table (7.2) displays the 
allocation of sujects from the original prognostic group into the 3 new groups. In the 
prognostic group I of the original low-risk cohort, 80 records of nodes ratio were 
labelled as missing and were predicted as category 1 (<=20% of positive nodes from 
removal). There are 125 nodes ratio missing values in the prognostic group 2 and 3 
records were deleted in the prediction process, 118 of the remaining missing values 
were predicted as category I and the rest were predicted as category 2 (20%-30%). A 
total of 258 records were predicted out of the original 268 nodes ratio missing values in 
the prognostic group 2, the number of records predicted to be nodes ratio category 1,2, 
3 and 4 are 248,4,1 and 5 respectively. Finally in the prognostic group 4,17 and 14 
records were predicted as category I and 4 respectively, I record was deleted. The 
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following table (7.3) summarises the attribute details of the variables in the model and 
the allocation of the predicted records of nodes ratio in the filled-in low-risk cohort 
analysis, The reallocation of unknown nodes ratio was followed a specific pattern. 
Original 
Prognostic Group 
Prognostic Group 
after Prediction 
Number of records 
1 1 75 
1 2 50 
1 3 1 
2 1 70 
2 2 105 
2 3 6 
3 1 2 
3 2 390 
3 3 72 
4 1 0 
4 2 1 
4 3 110 
Total: 882 
Table (7.2): Patient allocation to prognostic groups after filling-in missing data. 
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7.1.2 Cox regression analysis of filled-in missing data for the high-risk cohort 
The filled-in high-risk cohort now contains only 403 records since some of the filled-in 
values for pathological size have placed patients into the low-risk cohort. A total of 188 
cases were transferred to the filled low-risk cohort after following the clinical cohort 
separation criteria applied to the predictions of pathological size. Within these records, 
89 and 99 records were filled with values 1 and 2 respectively. Furthermore, 68,99 and 
21 out of 188 records were allocated into prognostic group 1,2 and 3 by the prognostic 
index for the low-risk cohort with the missing data filled-in. The predictive modelling 
for the filled high-risk cohort was carried out with 3-fold cross validation using the 
previously selected Cox model for the high-risk cohort, without interactions term. The 
patients were partitioned into 3 mortality risk groups with 105,167 and 131 patients, 
respectively, as shown in figure (7.4). A similar proportion of patients was allocated to 
each prognostic group as for the previous Cox model for this cohort. The results in 
figure (7.5) also show a better prediction of the survivorship function for each 
prognostic group. The mean survivorship of the 3 groups at 5 years is 0.60,0.35 and 
0.12. The attribute histograms, figure (7.6), show similar profiles to using missing 
values as separate attributes except for pathological size and nodes ratio, which do not 
show well differentiated profiles. 
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Figure (7.5): (a) The Cox predicted survivorship for prognostic groups of filled-in high- 
risk cohort and (b) the corresponding Kaplan-Meier estimate of the survivor functions. 
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Figure (7.6): The attribute histograms for prognostic groups of filled-in high-risk 
cohort. 
Table (7.4) displays the location of patients in the original prognostic groups and after 
the filling-in of pathological size and nodes ratio. In the Cox selected original model, 
pathological size and nodes ratio contained missing values is 196 and 257 cases, 
respectively. Table (7.5) and (7.6) summarise the number of records of each predicted 
value and their position in the new prognostic groups. A total of 6 missing values of 
pathological size were filled with value I and 190 records were filled with value 2. As 
expected, all the missing values of nodes ratio in this cohort were filled with value 1. 
Cox regression of filled HRG, orig model, monthly, PI group 3 
A 
23d 
Nude ieliu 
a121231234 
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Original prognostic 
group 
Prognostic group after filling-in the 
missing value 
Number of 
records 
1 1 47 
1 2 1 
1 3 0 
2 1 43 
2 2 146 
2 3 2 
3 1 5 
3 2 48 
3 3 111 
Total: 403 
Table (7.4): The patients allocation to prognostic groups after filling-in the missing 
data. 
Predicted value of 
pathological size 
Prognostic group after filling-in the 
missing value 
Number of 
records 
1 I I 
I 2 4 
I 3 I 
2 1 27 
2 2 83 
2 3 80 
Total: 196 
Table (7.5): The predicted value of pathological size and their location in prognostic 
groups. 
Table 
Predicted value of 
nodes ratio 
Prognostic Group after filling-in the 
missing value 
Number of 
records 
1 1 50 
1 2 117 
1 3 90 
Total: 257 
(7.6): The predicted value of nodes ratio and their locat ion in nrnannct is groups. 
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7.1.3 Discussion of the filled-in missing data analysis using Cox regression 
Patients in the low-risk cohort were merged into 3 prognostic groups from the original 4 
groups, which leads to allocation of patients differently to prognostic groups from the 
previous result. Hence, the attribute profiling looks more specific than the previous 
result in the low-risk cohort analysis. The different allocation of patients and the better 
attribute profiling are also repeated in the filled-in high-risk cohort analysis. In general, 
the accuracy of survival prediction was improved for the two sets of result and the 
filled-in values have not affected the distribution of the attributes in each prognostic 
group. However, some of the variables are not showing clearly differentiated attribute 
profiles. This possibly indicates that some of the variables in the models are no longer 
relevant to the data, hence, searching for a new optimal model for each of cohort is 
needed and summarised in section (7.2). Or else, it shows that interactions between 
variables are becoming more important, reported in section (6.5). 
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7.2 Independent model selection for the filled-in data 
7.2.1 Model selection for the filled-in low-risk cohort 
The Cox selected model for the low-risk cohort with missing data filled-in is similar to 
the Cox selected model for the low-risk cohort where the missing data were treated as 
separate category. Variable age group was selected additionally and nodes ratio was 
replaced by the number of nodes involved, which is a related variable. The new model 
contains node stage, histology, pathological size and number of nodes involved as well 
as age group. This was selected by forward stepwise elimination without variable 
interactions. Table (7.7) summarises the log likelihood and AIC values as each variable 
is entered into the model. The age group was the last variable entering the model and 
the reduction of AIC value from the last model was also the smallest. If there is a need 
of reducing the number of variables in the model, the age group would be the potential 
candidate. 
Variables entering the model -2 log L values Degrees of 
freedom 
AIC value 
Number of nodes involved 3421.25 3 3430.25 
Node stage 3404.01 4 3416.01 
Pathological size 3387.233 5 3402.233 
Histology 3378.392 7 3399.392 
Age group 3371.784 9 3398.784 
Table (7.7): The log likelihood and AIC value of each variable entering to the model 
which is selected for the completed low-risk cohort. 
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The prediction of survivorship was carried out with Cox regression using a 5-fold cross 
validation. As a result, a total of 4 prognostic groups are partitioned as showed in figure 
(7.7). Figure (7.8) displays the Cox predicted mean survivorship for prognostic groups 
with the corresponding Kaplan-Meier estimate survivor function and also, the attribute 
histograms for prognostic groups are shown in figure (7.9). 
The predictions from the newly selected model are almost identical to those predicted 
with missing values treated as separate attributes. By including the age group in the 
model, one more prognostic group was partitioned, compared with figure (7.1). The 
mean survivorship of prognostic groups at 5 years is 0.9,0.73,0.75 and 0.4. The 
attribute profiles also show that the attribute profiling for each variable is more specific, 
when compared with figure (7.3). 
45 
40 
35 
30 
25 
0 20 
15 
10 
5 
0 
PI of Co. regreesion for the fulled-in data using newly x-Ioct-d rnodal. HRGd 
[1 2 3 4 
A 
Q. 5 IiL LIILthILLL 
1 'I -lu. i 
Figure (7.7): The partitioned prognostic groups by the Cox regression using the newly 
selected model for the completed low-risk cohort. 
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Figure (7.8): The Cox predicted survivorship for the prognostic groups of completed 
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estimate survivor function. 
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Figure (7.9): The attribute histograms of the prognostic groups using the newly selected 
model for the completed low-risk cohort. 
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7.2.2 Model selection for the completed high-risk cohort 
7.2.2.1 The effect of sample size in the high-risk cohort 
Figure (7.10-7.12) displays three different sets of survival curves of clinical stage from 
three different sample conditions for the high-risk cohort. Figure (7.10) discards all the 
cases with pathological size value missing are discarded, that is assuming that the 
missing mechanism is at random and therefore the data distribution remains unaffected 
after missing values are removed. Figure (7.11) includes the cases where treating the 
pathological size missing values as a separate attribute, and figure (7.12) has the 
missing pathological size missing values predicted. Clearly, the survival curves of 
figure (7.11) are very different from the other two. From the highest to lowest 
survivorship, the clinical stage categories is in an order of 1,2,3 and 4, whereas the 
order was shown as 2,1,3 and 4 in the other two figures. 
It is concluded that representing missing values of pathological size as a separate 
attribute, results in the most differentiation between different prognostic risk groups, 
when compared to two alternative strategies. 
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Figure (7.10): The survival 
function of clinical stage 
from the high-risk cohort 
where the pathological size 
labelled as missing, were 
left out, only contained 209 
records. 
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Figure (7.11): The survival 
function of clinical stage 
from the high-risk cohort, 
coding pathological size 
missing values as a separate 
attribute, contained 633 
records. 
Figure (7.12): The survival 
function of clinical stage 
from the completed high- 
risk cohort where the 
missing pathological size 
has been predicted, 
contained 403 records. 
7.2.2.2 Model selection for the completed high-risk cohort 
The Cox selected model for the high-risk cohort estimating the missing values 
contained only 3 variables, namely age group, node stage and clinical stage. This was 
selected by forward stepwise elimination procedure and variable interactions were not 
considered. None of these variables contain missing data. 
Since the sample size is smaller than the other data set, the analysis is completed with a 
4-fold cross validation in order to have significant number of samples for training and 
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the results are displayed in figure (7.13) - (7.15) using the newly selected model. The 
results are shown in the order of prognostic groups partitioning, the Cox predicted 
survivorship with the Kaplan-Meier estimate of the survivor functions for each of the 
prognostic group and the corresponding attributes histograms. Note that four different 
prognostic groups were identified, one more than previously. Prognostic group 1, the 
highest survival group, only contains 30 patients, where the Kaplan-Meier estimation 
shows the mean survivorship is kept constant at the value of 1 for the first 19 months 
after surgery, then starts to decline gradually to the value of 0.83, remaining constant 
from month 39 onwards. The remaining groups contains 164,130 and 79 patients 
respectively and the corresponding survivorship after 5 years is 0.44 0.27 and 0.045. 
The predicted survivorships for all of the groups are consistent with the Kaplan-Meier 
confidence intervals. The highest survival group also shows a distinctive characteristic 
from the attribute profiles, where the attributes are concentrated on age group 3, node 
stage 0 and clinical stage 2. Then the age group changes from attribute 3 to loosely 
spread between 1 to 3, while clinical stage gradually moves from 2 to a sequence of 1,3 
and 4. Finally the node stage moves from 0 to 3 over the rest of prognostic groups. The 
variables clinical stage and node stage show clear differentiated attribute profiles from 
prognostic group 3 to 4 but the age group does not. 
-172- 
Chapter 7: Analysis of the results of filling-in the missing data 
Pl of Cox ragreesion for the filled-in data using newly selected modal. HRG 
12'34 
1 
IILLLi 2.5 3 3.5 F'I valure 
Figure (7.13): The partitioned prognostic groups by the Cox regression using the newly 
selected model for the completed high-risk cohort. 
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Figure (7.14): The Cox predicted survivorship for the prognostic groups of completed 
high-risk cohort using the newly selected model and the corresponding Kaplan-Meier 
estimate survivor function. 
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Figure (7.15): The attribute histograms of the prognostic groups using the newly 
selected model for the filled-in high-risk cohort. 
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7.3 Applying the Bayesian PLANN model to the original high-risk cohort using the 
Cox selected by filling-in the missing values for the high-risk cohort 
The Bayesian PLANN model was applied to the variables selected by Cox modelling of 
the completed high-risk cohort, aiming to investigate the possibility of variable 
interactions, and allow performance comparison with Cox regression. The network was 
evaluated with a 4-fold cross validation to define the prognostic index boundaries for 
the mortality risk groups. A total of 403 records were considered. The 3 variables 
selected by the Cox regression from the completed high-risk cohort were transformed 
into 9 binary input variables in the usual way, which together with the time variable 
formed the input layer, 18 hidden nodes were used and the single output node 
represented the conditional probability hazards in particular time intervals. Baseline 
attributes and grouped ARD technique were also used. 
The network was then applied to the 633 records of the original high-risk cohort which 
contained missing pathological size. Figure (7.16) displays the distribution of 
prognostic indexes from these 633 records and the pre-defined positions where 
aggregate mortality risk groups. The network predicted survivorship for each mortality 
risk group together with the corresponding Kaplan-Meier estimate of the survivor 
functions are displayed in figure (7.17), and the attribute profiles of prognostic groups 
are shown in figure (7.18). 
The highest survival group, prognostic group 1, contains 31 patients and appears to be a 
specific group of age group 3, nodes stage 0 and clinical stage 2 which is identical to 
the Cox partitioned prognostic group 1 in figure (7.14a). Prognostic groups 2,3 and 4 
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contain 384,142 and 76 patients, respectively, which are different from the Cox 
partition. However, there is no significant survivorship and attribute profiling difference 
from the results with Cox regression, suggesting that variable interactions between the 3 
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Figure (7.16): The calculated prognostic indexes for the original high-risk cohort which 
were gathered from network trained by the completed high-risk cohort using the Cox 
selected model from it. 
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Figure (7.17): (a): The network predicted survivorship for the prognostic groups in 
figure (7.16) and (b) the corresponding Kaplan-Meier estimate of the survivor 
functions. 
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Figure (7.18): The attribute histograms for the prognostic groups in figure (7.19), 
pathological size and tumour stage are also displayed to monitor the distribution of the 
patients with pathological size missing. 
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7.4 Discussion the adaptability of the regression method for missing data 
prediction 
In terms of the improvement to the survival prediction accuracy after filling-in the 
missing data, the survival predictions have been improved slightly but not significantly. 
For the low-risk cohort, the models selected before and after filling-in the missing data 
are very much the same, except that age group was selected additionally and nodes 
ratio was replaced by number of nodes involved, considering that the samples size of 
the two data sets are different. There is one more prognostic group is partitioned from 
the filled-in low-risk cohort analysis using the model selected from it, when comparing 
with the results obtain from the original data. The 5 years survivorship of the lowest 
survival group reduced from 0.52 to 0.4. 
The filled-in high-risk cohort contained much less samples, less than 2/3 of the original 
high-risk cohort. Figure (7.10-7.12) displays the different behaviour of clinical stage at 
the change of sample conditions, excluding the cases with the values of pathological 
size missing, including these cases as a separate attribute, and having them predicted. 
The model selected from the completed high-risk cohort only contained 3 variables. 
Two of them were already in the original model, but age group was added to the model. 
Again, an additional prognostic group was partitioned when using the model selected 
from the filled-in data and this group contained very few patients with very high 
survivorship. This group of patients was apparent again when this model was tested by 
the original data set. As a result, the 5-year survivorship of some of the other groups 
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was raised, which is the result of the existence of the records with pathological size 
missing in the data. These 3 variables are capable of identifying a very high survival 
group in the high-risk cohort, which the original model could not. Nevertheless, the 
Bayesian PLANN model analysis confirmed that there is no indication of significant 
variable interactions. 
It is concluded that filling-in the missing values in the data results is a more detailed 
breakdown of the prognostic risk groups than was possible from the original data set. 
This was due, in part, to the change in the allocation of records between the low- and 
high-risk cohort. 
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Chapter 8 
8. Validation of selected 
models with a new 
cohort of patient data 
I 
8.1 Test data Description 
8.2 Low-risk Cohort 
8.2.1 Cox regression analysis 
using Cox selected model without 
involving interaction term 
8.3 High-risk Cohort 
8.3.1 Cox regression analysis 
using Cox selected model without 
involving interaction term 
T+ 
8.2.2 Neural network analysis 
using Cox selected model 
T 
8.2.3.1 Cox regression analysis 
involving interaction term 
histology * node stage 
8.2.3.2 Cox regression analysis 
involving interaction term nodes 
ratio * node stage 
8.2.3.3 Cox regression analysis 
involving histology * node stage 
and nodes ratio * node stage 
8.3.2 Neural networks analysis 
using ARD selected model 
T 
8.3.3 Cox regression analysis 
involving interaction term 
Tumour Stage * nodes ratio 
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8. Evaluate modelling methods using a prospective test data set 
Cox regression and neural networks have been extensively applied in many medical 
applications. In particular, Cox regression has used for more than 20 years in medical 
survival analysis. Previous chapters have demonstrated the use and strength of each 
method. 
To investigate the robustness of each method further, the models fitted to a patient 
cohort recruited during 1983-89 were applied to a second cohort recruited between 1990 
- 93. These data acted as a validation set to evaluate the predictive value of the 
prognostic indexes derived by the Cox regression and the neural network model. For 
each method, the network weights and the cut-off points for prognostic group 
partitioning follow previously defined for the first patient cohort. 
8.1 Description of the validation data set 
The validation set comprises records from1653 new patients. Within these records, 388 
were discarded due to missing data, leaving 1265 cases for model validation. The data 
were divided into low- and high-risk cohorts, following the same separation criteria as 
used for the design data, resulting in 931 and 334 cases in each group, respectively. 
The population distribution of the two data sets is slightly different, as the validation 
data contains a higher proportion of low risk patients. Originally, there were 59% and 
41% of patients allocated to low-risk and high-risk cohort from the entire data set, but 
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for the second cohort these figures become 73.6% and 26.4%, respectively. Moreover, 
this characteristic also reflects in each of the variables as illustrated in appendix (II). For 
each of the variables, more patients are under the low-risk attributes than the first data 
set, the design data. 
Missing data were still a feature of the validation data set. Some of the variables even 
contain a higher portion of missing data than the design data, such as predominant site 
and histology in the high-risk cohort. However, the number of records contained 
missing data in nodes ratio has been reduced for both of low- and high-risk cohorts. 
8.2 Test data set low-risk cohort analysis 
8.2.1 Validating the Cox regression modelling method using low-risk cohort of 
validation set 
Previously, the low-risk cohort was implemented with 5-fold cross validation. All 
subjects in the low-risk cohort of validation set acts as a test set for each cross 
validation set of network weights, then five sets of results are collected and averaged as 
the final result for the low-risk cohort of validation set. The model fitted to the Cox 
regression is the Cox selected model for the low-risk cohort of design data, no 
interaction involved. The results for this cohort are displayed in figure (8.1) - (8.3). The 
Cox calculated prognostic indexes are shown in figure (8.1). The predicted mean 
survivorship for the prognostic groups is displayed in figure (8.2), together with the 
corresponding Kaplan-Meier estimate survival functions. The attribute histograms for 
each prognostic group are displayed in figure (8.3). 
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The Cox regression produces similar kind of survival prediction and attribute profiles as 
for the low-risk cohort of design data. However, the Kaplan-Meier estimates confirm 
that the survivorship of the low-risk cohort of the validation set is better than the Cox 
estimated for each prognostic group. The Cox estimation for each group contains 
around 0.1 error over 60 months on average. This is discussed further at the end of this 
chapter. 
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Figure (8.1): Cox regression calculated prognostic indexes for the low-risk cohort of 
validation set using the Cox regression selected variables for the original low-risk 
cohort, without involving interaction term. 
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Figure (8.2): The Cox regression predicted mean survivorship for prognostic groups, 
and the corresponding Kaplan-Meier estimate survivor functions. The Kaplan-Meier 
estimates confirm that the survivorship of the low-risk cohort of the validation set is 
better than Cox estimated. 
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Figure (8.3): The attribute profiles for prognostic groups of the low-risk cohort of the 
validation set using the Cox regression. The results show no distinguishable difference 
from the results for the low-risk cohort of design data with Cox regression. 
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8.2.2 Validating the neural networks modelling method using low-risk cohort of 
validation set 
The results for the low-risk cohort of the validation set were generated in the same way 
as with the Cox regression, by averaging predictions from 5 cross-validation networks. 
The network outputs were still marginalised toward the averaged hazard of the low-risk 
cohort of design data and the same prognostic index intervals were used for prognostic 
risk groups. The results are presented in figure (8.4) - (8.6), showing the partitioned 
prognostic groups using the intervals defined for the low-risk cohort of design data, the 
mean survivorship predicted by the network for each prognostic group and the 
corresponding Kaplan-Meier estimates of the survivorship functions, finally, the 
attribute histograms. 
The network predicted survivorship for the different prognostic groups is similar to the 
result for the low-risk cohort of design data using same approach in figure (5.19), and 
the corresponding observed survivorship has showed a better result except group 4, of 
which the observed survival rate is poorer than the predicted. Moreover, the attribute 
profiles show no distinguishable difference from previous result, figure (8.6). 
Results for the test data set can also be obtained by modelling the entire design data and 
tests by the validation set. Results from both approaches show no significant differences 
as illustrated in figure (8.7). The first approach does not require retraining with the 
complete data set, which is expensive computationally and maintains the consistency 
and fairness for result comparison. Therefore, all the results generated for the validation 
data set is completed by the first approach. 
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Figure (8.5): (a) The neural network predicted survivorship the pre-defined prognostic 
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Figure(8.6): The variable histograms for prognostic groups of low-risk cohort of 
validation set using the neural network. The results show no distinguishable difference 
from the results for low-risk cohort of design data on the same approach. 
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Figure (8.7): The network was trained with the design data and tested by the test set. 
(a): The network predicted survivorship for the pre-defined prognostic groups and (b): 
the corresponding Kaplan-Meier estimate of the survivor functions, resulting that no 
difference was made from the combined results for 5 cross validation sets, figure (8.5). 
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8.2.3 Validating the Cox regression method using the low-risk cohort of validation set 
involving interaction term 
The following is the analysis of Cox regression for the low-risk cohort of validation set 
involving different interaction terms. Details of the interaction terms and their effect on 
the survivorship of each group are listed in table (8.1). The predicted survivorship is 
similar with the results of the design data. 
Interaction term Effect 
Histology * node stage The highest survival group in the low- 
risk cohort has a survival rate > 0.95. 
nodes ratio * node stage The lowest survival group in the low- 
risk cohort has survival rate < 0.3. 
Histology * node stage, together with Lost the capability to accurately identify 
nodes ratio * node stage the lowest and the highest survival 
group. 
Table (8.1): Identified interaction terms for the low-risk cohort of design data and their 
effect on the group survivorship. 
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8.2.3.1 Inclusion of a pairwise interaction involvin histolo and node stcai'e e 7 
The low-risk cohort of validation set is fitted with a model consisting of pathological 
size, histology, nodes ratio and histology * node stage, shown for the design data in 
section (6.5.1) and Cox results for the validation data are summarised in figures (8.8) - 
(8.10), showing that the specification of two groups f population is lost, group I and 
group 4. They are corresponding to the highest and the lowest survival group in the low- 
risk cohort of design data. 
Prognostic indexes of new LRG. Cox ivolved hist"n 
Figure (8.8): The Cox regression calculated prognostic groups involving interaction 
term, histology and node stage, only two prognostic groups are recorded. 
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Figure (8.9): The Cox regression predicted survivorship for the 2 prognostic groups 
involving interaction term, histology and node stage, and the corresponding Kaplan- 
Meier estimate of the survivor functions. The observed survivorship for both groups is 
better than predicted by Cox regression. 
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Figure (8.10): The attribute histograms for the prognostic groups of Cox regression 
involving interaction term. The results show no distinguishable difference from the low- 
risk cohort of design data result involving interaction term, histology and node stage, on 
the same approach. 
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8.2.3.2 Inclusion of a pairwise interaction involving nodes ratio and node stage 
A model comprising node stage, pathological size, histology and nodes ratio * node 
stage identifies the lowest survival group in the low-risk cohort, of which the 
survivorship is below 0.3 as shown in the Cox's prediction for the low-risk cohort of the 
validation set, figure (8.12). This suggests that the interaction between nodes ratio * 
node stage is important to the group with very low survival. The Cox prediction and 
attribute profiles show no different from previous results using same model as in section 
(6.5.2), except that the observed survivorship for each patient group has improved 
compared to the model predictions in figure (8.12). Clearly, group I and 2 are brought 
closer together towards a probability of 1. 
Prognostic indexes of new LRG, Cox ivolved node ratio "n 
Figure (8.11): The Cox regression partitioned prognostic groups involving interaction 
term nodes ratio and node stage. 
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Figure (8.12): The Cox regression predicted survivorship involving interaction term 
nodes ratio and node stage for the prognostic groups of low-risk cohort of validation set 
and their corresponding Kaplan-Meier estimate of the survivor functions. 
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8.2.3.3 Inclusion of interaction terms histology * node stage together with nodes ratio * 
node stage 
The model containing two interaction terms comparises histology, pathological size, 
histology * node stage and nodes ratio * node stage. Previous results have shown the 
individual characteristics of these two interaction terms cannot be merged by bringing 
them together into a single model, section (6.5.3). This applies also to the new data set, 
as the results show no significant difference from previous results in section (6.5.3), 
including the attribute profiles. The observed survivorship for each patient group is 
again higher than for the design data. 
Prognostic indexes of new LRG. Cox ivolved node rMio" n. hist'n 
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Figure (8.14): The Cox regression partitioned prognostic groups involving interaction 
terms histology and node stage, nodes ratio and node stage 
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Figure (8.15): The Cox regression predicted survivorship for the prognostic groups 
involving interaction terms histology and node stage, nodes ratio and node stage and 
the corresponding Kaplan-Meier estimate of the survivor functions. The observed 
survivorship of the four prognostic groups is better than estimated. 
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Figure (8.16): The attribute histograms for the prognostic groups of Cox regression 
involving interaction terms histology and node stage, nodes ratio and node stage. The 
results show no distinguishable difference from the previous result on the same 
approach. 
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8.3 validation data set high-risk cohort analysis 
8.3.1 Validating the Cox regression modelling method using the high-risk cohort of 
validation data set 
The Cox regression results for the high-risk cohort of validation set were averaged over 
the 3 cross-validation sets with a model comprising menopausal status, predominant 
site, tumor stage, node stage, histology and nodes ratio. The results are presented as the 
follows: figure (8.17) illustrates the distribution of prognostic indexes, the Cox 
regression predicted survivorship for each prognostic groups are displayed in figure 
(8.18) together with the corresponding Kaplan-Meier estimates survival function, and 
the attribute histograms for prognostic groups are displayed in figure (8.19). 
The predicted survival rates remain consistent with those expected from the design data, 
but the highest risk group now shows an increase in 5-year survival to around 0.3. This 
indicates that there may have been a significant improvement in the effectiveness of 
care for this patient group. 
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Figure (8.17): The Cox regression calculated prognostic indexes and divided prognostic 
groups for the high-risk cohort of validation set. 
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Figure (8.18): The Cox regression predicted survivorship for prognostic groups and the 
corresponding Kaplan-Meier estimate of the survivor functions. The survival prediction 
for prognostic group 3 contains 0.2 error. 
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Figure (8.19): The attribute histograms for the prognostic groups. The results show no 
distinguishable difference from the results on the same approach. 
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8.3.2 Validating the neural network model with the high-risk cohort of validation set 
A similar study to that carried out for Cox regression, was performed also with the 
PLANN model. Figure (8.20) shows distribution of the prognostic indexes and its 
partition into different groups using the same intervals as are shown in figure (6.1). 
Figure (8.21) illustrates the network predicted survivorship for prognostic groups and 
the Kaplan-Meier estimate of the survivor functions. Finally, the attribute profiles for 
the prognostic groups are displayed in figure (8.22). The results with the ARD selected 
model are presented in figure (8.23) - figure (8.25) in the same order. Both sets of 
results show similar survival predictions as for the high-risk cohort in the design data 
and no distinguishable difference is observed in the attribute profiles. As for Cox 
regression, there is a noticeable improvement in survival for the group at highest 
mortality risk. 
Prognostic indexs of validation set HRG 
Figure (8.20): The neural networks calculated prognostic indexes and partitioned 
prognostic groups using the Cox selected model for the original high-risk cohort 
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Bayesian networks estimated survival of validation set. Cox selected, HRG Kaplan-Meier estimated survival of validation net. Cox selected. HRG 
Figure (8.21): The neural networks predicted survivorship for the prognostic groups 
using the Cox selected model and the corresponding Kaplan-Meier estimate of the 
survivor functions. Only the performance of prognostic group 3 is not met the 
expectation as the other groups. 
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Figure (8.22): The attribute histograms for the prognostic groups using Cox selected 
model. The results show no distinguishable difference from the results for high-risk 
cohort of design data on the same approach. 
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Figure (8.23): The neural networks calculated prognostic indexes and prognostic groups 
using the ARD selected model for the original high-risk cohort. 
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Figure (8.24): The neural networks predicted survivorship for the prognostic groups 
using the ARD selected model and the corresponding Kaplan-Meier estimate of the 
survivor functions. Both of the prognostic group I and 3 have shown a higher 
survivorship than the neural networks predicted. 
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Figure (8.25): The attribute histograms for the prognostic groups of neural networks 
using the ARD selected model. The results show no distinguishable difference from the 
result for the high-risk cohort of design data on the same approach. 
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8.3.3 Validating the Cox regression method using the high-risk cohort of validation 
set involving interaction term 
As shown in section (6.3), the best model for the high risk cohort consists of clinical 
stage, and the pairwise interaction nodes ratio * tumour stage. The results of the high- 
risk cohort of validation set fitted to this model are displayed in figures (8.26) - (8.28), 
combining the predictions from 3-fold cross validation. The Cox predicted survivorship 
for each prognostic group is as accurate as the Kaplan-Meier estimates and similar 
proportion of patients allocated to prognostic groups to the previous results in section 
(6.3). However, the results show that the predicted survivor function for prognostic 
groups 1 and 3 are different from the results shown in figure (6.8a). The predicted 
survival for prognostic group I has reduced from 0.78 to 0.66 and for group 3 it has 
increased from 0.08 to 0.3.. 
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- I , Figure (8.26): The Cox regression partitioned prognostic groups involving interaction 
term tumour stage * nodes ratio. The three prognostic groups contained 130,138 and 
66 patients respectively. 
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Figure (8.27): The Cox regression estimated survival curves for each of the prognostic 
groups involving interaction terms nodes ratio * tumour stage and their corresponding 
Kaplan-Meier estimated survival curves. 
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Figure (8.28): The attribute histograms for the prognostic groups of Cox regression 
involving interaction terms tumour stage * nodes ratio. 
- 205 - 
Chapter 8: Validation of selected models with a new cohort of patient data 
8.4 Discussion of test data set analysis 
From the results for the validation data, it can be concluded that the overall survivorship 
improved since the previous cohort and the survival prediction by different modelling 
methods for the test data set is similar with the prediction made for the design data. The 
results also show change of population where the predicted survivorship is similar with 
the Kaplan-Meier estimate but they are different from the results for the design data, as 
shown in the high-risk cohort interaction analysis in section (8.3.3). In both models, the 
Cox regression and PLANN, the attribute profiles have not shown significant 
differences between the training and validation cohorts, with the exception of the high- 
risk cohort with a pairwise interaction term. The survivorship of breast cancer for the 
high-risk patients improved since the early of 90's at least by 0.2. On the other hand, the 
survivorship for the patient groups in the low-risk cohort has also improved but not as 
much as for the high-risk cohort. Moreover, the two sets of data have shown a different 
population distribution with fewer patients at the high risk. 
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Chapter 9: Summary and Conclusions 
9.1 Summary 
9.1.1 The changes of breast cancer prognosis within 10 years 
Two sets of breast cancer data were considered in this thesis. They are cohorts of 
patients recruited by Christie Hospital during 1983 to 1989, and 1990 to 1993 each time 
with five years of follow-up. The attribute distributions in the two sets of data are 
different. There are fewer high-risk patients in the second cohort, and their 5-years 
survivorship is improved compared with same prognostic groups in the earlier cohort. 
This may reflect improvements in patient care, summarised in chapter (8). 
Missing data are unavoidable, and this is present also in the second data set, even 
though the quality of the data provided is excellent. If there is only a relatively small 
amount of missing data in the entire data set, then those records can be simply 
discarded. Otherwise, they need to be handled carefully. Using the mean value of the 
variable is one of the commonly used methods to fill the missing values for continuous 
data. However, the situation becomes complicated in the case of categorical data. 
Within this thesis, we suggested using Nominal Logistic Regression to predict missing 
values, which required the identification a set of complete predictor variables for each 
variable with missing data. However, the values predicted by logistic regression may 
not be free of bias and there is no significant change to the survival predictions. Ripley 
(1998) also reported that filling in missing data using regression or other methods may 
not result in significant improvements to the data analysis. Therefore, treating the 
missing data as a separate category within the variable is a safe and efficient way to 
handle categorical missing data. 
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9.1.2 Results obtained with Cox regression and Kaplan-Meier estimation 
9.1 21 Kaplan-Meier estimation 
Kaplan-Meier estimation is a non-parametric model of survivorship. The role of this 
estimation in the thesis is to describe the survivorship of patients in different prognostic 
groups generated by the Cox regression or the neural networks, and hence to ascertain 
the accuracy of the survival predictions made by each modelling method. A 95% 
confidence interval is calculated for each survival curve. 
9.1.2.2 Cox re rem ssion 
Cox regression has been the method of choice in medical survival modelling since it 
was first proposed in 1972. The robustness, flexibility and commercial availability of 
software are some of the factors that contribute to the popularity of this method. Within 
this thesis, Cox regression was used both for variable selection and as a direct 
modelling methodology. The neural networks approach confirmed that the data are only 
slightly off the proportional hazard assumption. Cox models selected with the AIC 
criteria were still capable of producing good differentiation and accurate survival 
prediction for prognostic groups by mortality risk. 
Chapter 9: Summary and Conclusions 
9.1.3 Neural network modelling with PLANN 
In this thesis, the use of a Bayesian framework to regularise the Partial Logistic 
Artificial neural network with in the evidence approximation is demonstrated to be able 
to model censored survival data accurately on a monthly basis. The marginalisation 
procedure has to be improved because the output variable is not balanced between class 
labels, which involves a modification to the cost function, and the gradient and the 
Hessian calculations. This moderates the network towards the best unconditional 
estimate of the output which for us, is the mean hazard. Then Bayes' theorem is used to 
refer the estimates of the predicted hazard back to the true priors. Categorical data also 
has be handled differently in the PLANN network, by assigning one of the attributes as 
the baseline. Then the rest of the attributes corresponding to each variable share the 
same value of regularisation coefficient, and ARD is used for variable selection. 
Variable interactions can be naturally mapped within the network structure, but the 
explicit relationship between variables is difficult to trace. 
The potential of the Bayesian regularisation framework applied to PLANN was 
explored in this thesis and it was concluded that the network performance in prognostic 
group differentiation and survival prediction is comparable to that of Cox regression, 
having the further advantage that: 
" The proportionality of the hazards need not be observed. 
  The network output is a smoothed hazard over time. 
Since the Bayesian PLANN model is capable of handling non-linearity in the data, it is 
further capable of: 
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  Handling arbitrous interactions. 
  Handling non-linear covariate time dependencies. 
  Supporting variable selection, using ARD. 
9.1.4 Performance comparison of Cox regression and the neural networks analysis 
The neural network model and Cox regression separate patients into prognostic groups 
differently, as summarised in appendix (III). The neural network prognostic groups 
whose attribute profiles are more specific than the Cox regression without variable 
interactions. The ARD technique can be used for model selection, which has been 
demonstrated in the analysis of high-risk cohort, summarised in chapter (6) in which the 
selected variables implicitly take into account of variable interactions. 
In the low-risk cohort, PLANN provided candidate terms for pairwise interactions, from 
which Cox regression found two pairs that contribute to two different prognostic 
groups, as described in section (6.5). However, these two pairs of interacting variables 
work against each other in Cox regression, but lead to better prognostic group 
separation if modelled with PLANN. 
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However, training the neural network for such large data set is computational time 
consuming and the ARD model selection process is also not straightforward. 
The 
weight decay hyper-parameters computed for each variable are not consistent when the 
network was trained repeatedly with different initial conditions, causing changes to their 
rank order. In this thesis, the network was trained with all available 
input variables at 
the beginning, then gradually eliminated the variables with the largest value of the 
weight decay parameter, alpha, until no more variables can be discarded without serious 
reduction in performance. There is no clear guidance to assist in the use of ARD for 
model selection. Moreover, the network predictions become less accurate when the data 
uncertainty is large, since they are marginalised towards averaged hazard of the data. 
For its part, Cox regression is widely available in commercial and it is easy to use. Also 
the demand of computational time is limited. As the analysis of the validation data set in 
chapter (8) showed, the Cox regression is not much affected by the data uncertainty and 
produces good estimation of survivorship for each prognostic group. Moreover, it 
captures the shape of a survivor function over time in better detail. 
The Cox regression performed well even when the proportional hazards assumption is 
not strictly observed and showed similar results when the method was tested by the 
validation data set, which has demonstrated the robustness of this approach. 
However, the Cox regression in variable interactions must be pre-specified, but it is 
difficult to include all the combination of variable interactions for model selection when 
many variables are present. 
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Differentiation has been observed for the models with interaction terms for both cohorts 
in the design data, in which the prognostic groups are less overlapped and the accuracy 
of survival predictions for each group is considerably more accurate. On the other hand, 
the overall improvement of survivorship is apparent for all groups in the low-risk cohort 
of validation data set. However, there is no evidence suggested a systematic 
improvement in the high-risk cohort for any prognostic groups. Particularly for the 
lowest survival group, identified either by the models with or without interaction terms, 
has shown a clear survivorship improvement for each model but not the case for the 
other groups. Only the model with interaction term is capable of providing an accurate 
survival prediction for the lowest survival group while the other models suggest a lower 
survivorship should be for this group according to the covariate values. 
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9.2 Conclusions 
Smith (2000) points out that an increasing number of patients do not benefit from 
systemic therapy, when systemic therapy is only offered to patients with tumours larger 
than lcm in diameter. With the widespread use of mammographic screening programs, 
the average tumour is now in the 1.5-cm range at diagnosis. Throughout this thesis, the 
survivorship of prognostic groups in each cohort modelled in detail, in which a high risk 
patient group in the low-risk cohort was identified. A low risk patient group in the high- 
risk cohort was also identified, who might have gone through the rigors treatments 
unnecessarily. 
In terms of the development of the neural network methodology for censored survival 
data, in chapter (5), the PLANN model was extended with regularisation within a 
Bayesian approximation for the hyperparameters. This gives an automatic determination 
of suitable values for the regularisation parameters requiring adjustments only to the 
number of nodes in the hidden layer. It results in smooth estimates of the discrete time 
hazard and allows for non-proportionality and non-linear interactions between 
covariates. In order to handle the categorical data more effectively, the ARD technique 
was modified to suit the data structure, in which several inputs corresponding to same 
variable share same value of alpha hyperparameter, and also the baseline attributes 
referral. The target distribution is very unbalanced, which requires a modification to the 
training algorithms and to the estimation of the conditional hazard with the result that 
the network outputs are marginalised towards the data averaged hazard. The use of 
ARD technique for soft pruning are also demonstrated, which is useful to determine a 
parsimonious neural network model. 
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In terms of the data analysis technique, we proposed dividing patients into prognostic 
groups using the log-rank test to group the calculated prognostic indexes into mortality 
risk group. This was interpreted by displaying the attribute profiles for each prognostic 
group using the selected variables. The extended Bayesian PLANN model and Cox 
regression were optimised by a monthly analysis of 5 years for two cohorts of patients, 
defined by clinical staging to be low- and high-risk cohort. In each cohort, prognostic 
indexes for mortality risk groups are formulated. For each method, the mean 
survivorship for each prognostic group is estimated and compared with the Kaplan- 
Meier estimate derived from the observed survival of those patients. It is summarised in 
chapters (4) and (5). Using PLANN to identify candidate pairwise interactions to 
include in a Cox regression model, a term involving nodes ratio * tumour stage was 
found to be useful in determining a specific high mortality group within the high-risk 
cohort, and for the low-risk cohort, two pairwise of interaction terms are also found, 
each corresponding to a high mortality group and a low mortality group separately. It is 
reported in chapter (6). 
A second cohort of patients was used to validate the methodologies and their 
corresponding results for the first data set, which is summarised in chapter (8). Results 
showed that the population characteristics of two sets of data are different, for instance 
the two groups of patients identified by the interaction term histology * node stage from 
the low-risk cohort is no longer present in the second data set, appendix (III). A 
comparison of the model prediction with the Kaplan-Meier estimates shows an 
improvement in survival for the validation data set. 
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It was also proposed to use nominal logistic regression to predict the categorical 
missing data. However, the efforts have not been rewarded with significant 
improvement to the analysis. Therefore, treating the missing data as a separate category 
is the sage and most efficient way to handle categorical missing data, as summarised in 
chapter (7). 
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9.3 Further Work 
The study could be extended to ten years allowing a more detailed study of possible 
deviations from the proportional hazards assumption over longer periods of time. 
Accurate survival estimation would provide useful information to enable the clinicians 
and patients to make better informal discussion and decision regarding treatments and 
surgery. 
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Kaplan-Meier estimate of the survival functions for the low-risk cohort of design 
data 
0.1 
0 
K NsuMel pbta of tJatoMueel sMW In LRß 
10 50 20 30 40 Oms in NdttM. 
Menopausal Status 
K-IJ suwl plol  of Sdo In LHC3 
Side 
KJN plot" d ßaEOmtrwr &1O In LRO 
Predominant Site 
00 
KM urVW Plý at Ago OmY In LAD 
Diameter 
0.9 
aa 
as 
ae 
L o. 
ýLy 0.4 
a] 
0.2 
OA 
ýý 
I -- 
Age Group 
KMpICI"ofüurtirnlKG 
KN pbn of HYtdopy h lR0 
-1 
A2 
-3 
o 10 20 30 40 
Tlme in MOnfr 
Histology 
so m 
ý:., ý 
-231- 
LIVERPOOL JOHN MOORES UNIVFRSiTV I FAPp lIKIn o 
O' l 
0.9 
0.8 
0.7 
I 
4 
06 
0.5 
0.4 
0.9 
O. 1 
0.1 
04- 
0 
KN plds of Ptlnbdeel sRe ti Lfäi 
Pathological Size 
K-M plop tl Node Nape n LRG 
10 20 30 40 
Ti.. n NorMhs 
Node Stage 
50 so 
K-M PlOtS d Nunbbr Of NoUr imduE in LFaG 
ýo 
O- 13 
4ý 
tm mary 'I 
w- Missnp 
.i 
10 20 30 40 
TMn. n Nmlhe so 
Number of Nodes Involved 
10 
H-M pots of NoEr Rrio in LRß 
ý--r-ý - 
20 JO -- b --_ 
ý- 
TYnO in Naxh. 
Nodes Ratio 
60 
60 
I j 
° m ý 
ýT 
E o. s 
0.1 
0L. - - 0 
- 232 - 
Kds plds of Tumour Yaiia in LRO 
Tumour Stage 
K-M plot. of N. la. t.. i. tuapa in LRG 
10 30 40 SO BO 
Tm" n NGn1ha 
Metastasis Stage 
K-M plat a Numfsr of Nodr fiýoro n LRO 
10 30 tl 50 Tme in NoMlr 
Number of Nodes Removed 
KJJ Plots of Clinical Stege (U. hrlar staps) in Vt0 
10 20 30 40 
il. * In NonIM 
80 
60 
Clinical Stage (Manchester Stage) 
I 
4 
0.9 
0. e 
0.7 
0.6 
0. s 
0.4 
0.3 
0.2 
0.1 
0. 
0 
K-01 plah d ONMaW M LAG 
unmow, (*s) 
Missnil 
10 20 30 10 
Tms in NonIM 
Oestrogen 
K-N plots of Surgery In IRG 
- Ný -4- 2 
3 
4 
5 
8 
7 
Surgery 
so 
0.9 
0.8 
0.8 
os 
e}ý 
04 
e 03 
O. 7 
0.1 
0, 
0 
I ý 
u 
ýi+t 
E 
0.9F 
o. eF- 
0.7 F 
0.6)- 
0.5F 
a. sF- 
0.3F 
O. 2 F 
o. 1 F- 
10 
_NO O Yr 
K-M pld" d TrrlrtMrt in LRß 
Nm 1 
2 
3 
ý4 
8 
e 
-9 10 
20 30 40 
'nm* n Nanttti 
Treatment 
KJU PION of Rblatlisgy In LAO 
_r 
50 
OL----_ `-- ý -- _, -- - -- _. . --- 
10 20 30 40 50 
11mo in Ndthg 
Radiotherapy 
00 
Kaplan-Meier estimate of the survival functions for the high-risk cohort of design 
data. 
Menopausal Status 
K-M pots of SIRS for MRß 
Side 
ý 
ý 
m 
Qi 
Ä 
ý 
K-M plop d Prstbninart Sie br HRß 
-. Uppr OilW 
P Lý Oiaar 
Uppwrlmrr 
Lý Innwr 
-ý Sý6antlr 
Niu rq 
0.1 
I ý 
ý ý 
ý 
ý 
Age Group 
KN pda Co DlNmalr br NRCi 
o 10 3.0- 
a 
rime n Nari. 
Diameter 
MN plots of Mlttob0y for NR(3 
so 
.-1 
os 3 
MisaMp 
10 20 30 40 SO E0 
Tm. In Manlh. 
Predominant Site II Histology 
K-N pots of T-u St. g. M MPG 
Qf 
0.3F 
aYF 
III 
0.1 
10 40 50 90 
KaM Otots of Nods Stags for HRO 
0 10 
0.9 
o. e 
a. e 
t 0.3 
Tý 
0.3 
0.2 
0.1 
OL 
0 
20 30 40 50 
7ºns n Mortt. 
Node Stage 
K-M pkMs of Numaw of had= kroNStl b NRß 
o 
9 1-3 
-- N 
may 
+ Nhshp 
Number of Nodes Involved 
d-Oty4W99 
K-N plots of fbOr RMb Ir RRCi 
1 
00 
AAAAAAAM 
acoq 
I =2PA 
A 20- 30-A 
3"0'A 
BML 
-ý- NMeYp 
I0 
öoc+eoeseaeseao 
ý ,ý 50 Time In Manus 
Nodes Ratio 
60 
I I 
Tu 
Y 
E 
-235- 
10 
Metastasis Stage 
K-N pats of P Lmbw of Neer FW-wd br NR8 
20 30 40 
,. n. h NrntM 
50 
K-M plots of Matstt. Y Stage for MRS 
10 20 50 40 50 
N ne h North 
Number of nodes Removed 
an 
60 
K-N pats of Clnlcat Stag. (Rlamnnter Stop) Rx MRO 
so 
ll-- 
eo 
I Clinical Stage (Manchester Stage)_ 
PAGE 
NUMBERING 
AS 
ORIGINAL 
Appendix (il) 
The variation of sample distribution for the selected variables of the design and the 
validation data set. 
Low-Risk Cohort of the Design Data 
Clinical Node Stage 
Category Frequency Percentage 
0 734 80 
1 183 20 
total 917 100 
Pathologic I Size 
Category Frequency Percentage 
1 383 41.8 
2 534 58.2 
total 917 100 
Histology 
Category Frequency Percentage 
1 724 79 
2 95 10.4 
3 98 10.7 
total 917 100 
Nodes Ratio 
Category Frequency Percentage 
<20% 256 27.9 
20-30% 18 2.0 
30-60% 40 4.4 
60+% 98 10.7 
Missing 505 55.1 
total 917 100 
Low-Risk Cohort of the Validation Data 
Clinical Nod e Stage 
Category Frequency Percentage 
0 800 85.9 
1 131 14.4 
total 931 100 
Pathological Size 
Category Frequency Percentage 
1 541 58.1 
2 390 41.9 
total 931 100 
Histology 
Category Frequency Percentage 
1 633 68.0 
2 111 11.6 
3 187 20.1 
total 931 100 
Nodes Rati o 
Category Frequency Percentage 
<20% 624 67.0 
20-30% 28 3.0 
30-60% 51 5.5 
60+% 43 4.6 
Missing 185 19.9 
total 931 100 
High Risk Cohort of the Design data 
Meno ausa l Status 
Cate or Fre uenc Percenta e 
1 177 28.0 
2 36 5.7 
3 420 66.4 
Total 633 100 
Clinical Node Stage 
Category Frequency Percentage 
0 355 56.1 
1 186 29.4 
2 48 7.6 
3 44 7.0 
Total 633 100 
Clinical Sta e 
Category Frequency Percentage 
1 184 29.1 
2 171 27.0 
3 165 26.1 
4 113 17.9 
Total 633 100 
Predominan t Site 
Category Frequency Percentage 
1 256 40.4 
2 54 8.5 
3 103 16.3 
4 38 6.0 
5 158 25.0 
Unknown 24 3.8 
Total 633 100 
Tumour Stage 
Category Frequency Percentage 
1 68 10.7 
2 186 29.4 
3 156 24.6 
4 223 35.2 
Total 633 100 
High-Risk Cohort of the Validation data 
Menopausa l Status 
Category Frequency Percents e 
1 107 32.0 
2 16 4.8 
3 211 63.2 
total 334 100 
Clinical Node Stage 
Category Frequency Percentage 
0 199 59.6 
1 100 29.9 
2 25 7.5 
3 10 3.0 
total 334 100 
Clinical Sta ge 
Category Frequency Percentage 
1 57 17.1 
2 109 32.6 
3 79 23.7 
4 89 26.6 
total 334 100 
Predomina nt Site 
Category Frequency Percentage 
1 143 42.8 
2 17 5.1 
3 40 12.0 
4 14 4.2 
5 59 17.7 
Unknown 61 18.3 
Total 334 100 
Tumour Sta ge 
Category Frequency Percentage 
1 57 17.1 
2 109 32.6 
3 79 23.7 
4 89 26.6 
Total 334 100 
High Risk Cohort of the Design data 
Pathological Size 
Category Frequency Percentage 
<2cm 14 2.2 
2-5cm 134 21.2 
5+cm 71 11.2 
Missing 414 65.4 
Total 633 100 
Histology 
Category Frequena Percentage 
1 362 57.2 
2 78 12.3 
3 189 29.9 
Missing 4 0.6 
total 633 100 
Nodes Ratio 
Category Frequency Percentage 
<20% 91 14.4 
20-30% 5 0.8 
30-60% 28 4.4 
60+% 92 14.5 
Missing 417 65.9 
total 633 100 
High-Risk Cohort of the Validation data 
Pathological Size 
_Category 
Frequency Percentage 
<2cm 12 3.6 
2-5cm 51 15.3 
5+cm 51 15.3 
Missing 220 65.9 
Total 633 100 
Histology 
Category Frequency Percentage 
1 164 49.1 
2 33 9.9 
3 97 29.0 
Missing 40 12.0 
total 334 100 
Nodes Ratio 
Category Frequency Percentage 
<20% 102 30.5 
20-30% 17 5.1 
30-60% 22 6.6 
60+% 45 13.5 
Missing 148 44.3 
total 334 100 
Appendix (III) 
The number of patients in each prognostic group of design data for Cox regression and 
neural network models. 
Low-risk cohort: D- Design data (917 cases), T- Test data (931 cases) 
Prognostic Prognostic Prognostic Prognostic 
group 1 group 2 group 3 group 4 
D T D T D T D T 
Cox Regression 127 229 189 355 487 237 114 110 
Neural Networks using 56 126 359 461 460 328 42 16 
Cox Model 
Cox Regression Involving 61 0 207 610 579 321 68 0 
Interaction Term 
(Histology *Node Stage) 
Cox Regression Involving 116 237 331 375 427 303 43 16 
Interaction Term 
(Nodes ratio*Node Stage) 
High-risk cohort: D- Design data (613 cases), T- Test data (334 cases) 
Prognostic Prognostic Prognostic 
group 1 group 2 group 3 
D T D T D T 
Cox Regression 171 126 275 129 187 78 
Neural Networks using Cox 248 125 174 69 211 140 
Model 
Neural Networks ARD model 244 99 171 87 218 148 
Cox Regression Involving 214 130 278 138 139 66 
Interaction Term 
(nodes ratio*tuinour stage) 
